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ABSTRACT 
Investigating the causes of ageing on the myocardium is especially important for the 
future health of Australia's ageing population, which is increasing due to increased life 
expectancy (AIHW, 1999). 
Cardiovascular disease is currently Australia's greatest health problem (AIHW, 1999), 
and since the aged population is most commonly affected by this disease (HSVD, 
1999), investigating the causes of ageing of the myocardium and the predisposing 
factors of cardiovascular disease, is important for the future health of Australia's ageing 
population. 
In this study, male and female Wistar rats [young (n = 8, aged 12-30 weeks old), middle 
aged (n = 6, 1-1.5 years old) and senescent (n = 7, 2-2.5 years old)] had cardiac tissue 
removed for contractile, histological and morphometric analysis. 
The data derived from the contractile investigations comparing young, middle-aged and 
senescent rats, do not demonstrate any major differences across the age spectrum. For 
the contractile analysis, mitochondria were inactivated and an exogenous energy supply 
was used. The results showed that the cardiomyocytes are able to develop the same 
levels of force regardless of age, suggesting that it is the mitochondria that exert an 
influence on ageing cardiomyocyte contractile function. 
Statistical analysis of one contractile parameter (pSr10, the pSr that produces 10% of 
maximum activated force) yielded a significant (P < 0.05) difference between young 
and middle-aged rats, and young and senescent rats. It was speculated that these results 
might reflect a developmental change in the Troponin C (TnC) protein that may only 
occur early in life ie. between young and middle-age in the rat. 
During the histological and morphometric analyses, significant (P < 0.05) changes were 
observed in the volume of mitochondria, cytoplasm and 'other' structures, in both sides 
of the heart, when comparing young, middle-aged and senescent rats. In the left side of 
the heart the volume of mitochondria significantly (P < 0.05) decreased whilst the 
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volume of cytoplasm significantly (P < 0.05) increased with age. This provides further 
evidence of the influence of mitochondria on the functioning of the ageing heart. 
In the right side of the heart, the volume of mitochondria significantly decreased 
between young and middle-aged rats, then significantly (P < 0.05) increased between 
middle-aged and senescent rats. The volume of cytoplasm significantly (P < 0. 05) 
increased between young and middle-aged rats whilst the volume of 'other' structures 
ie. connective tissue, vascular and interstitial space, significantly (P < 0.05) decreased 
between middle-aged and senescent rats. 
The knowledge gained from the current investigation will further the information 
already available on the effects of ageing on the myocardium. The results will be 
discussed in terms of human myocardial ageing. 
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CHAPTER 1 
INTRODUCTION 
13 
--
.............__ 
1.1 BACKGROUND TO THE STUDY 
The present study investigates the effects of ageing on rat myocardium at the cellular 
level. Two different techniques were used. Firstly, contractile investigations and secondly 
histological and morphometric analyses. In combination, these techniques will be used to 
study functional and structural changes with age in myocardial tissue. The results of both 
techniques were correlated and analysed in comparison to reports in scientific and 
medical literature. 
The literature review details the current knowledge available regarding the effects of 
ageing on the myocardium; incorporating theories of ageing, free radical damage, 
mitochondrial changes with age, apoptosis and changes in protein structure and other 
cellular components within individual muscle cells of the myocardium. 
1.2 SIGNIFICANCE OF THE STUDY 
Investigating the effects of ageing on myocardium is important, due to cardiovascular 
disease being Australia's greatest health problem (AIHW, 1999). In addition, the aged 
population is increasing due to increased life expectancy (AIHW, 1999). 
With the above information in mind, this study will contribute to the knowledge of the 
effects of ageing on the myocardium as well as help in the identification of the causes of 
ageing. The information yielded will also help in the treatment of diseases and conditions 
that occur in the myocardium as a result of ageing. 
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1.3 RESEARCH QUESTIONS 
• What are the effects of ageing on the function of the contractile and regulatory 
proteins of myocardium? 
• What are the effects of ageing on the volume of mitochondria in myocardium? 
• Is there a relationship between the function of the myocardium and the volume of 
mitochondria? 
1.4 HYPOTHESES 
• That there will be a difference in the kinetics of calcium and strontium activated force 
in senescent cardiomyocytes in comparison to young cardiomyocytes. 
• That the volume of mitochondria in senescent cardiomyocytes will be greater than 
the volume of mitochondria in young cardiomyocytes. 
15 
CHAPTER 2 
LITERATURE REVIEW 
16 
--
2.1 AGEING 
Understanding the effects of ageing on the myocardium has taken on special significance 
in recent years, as cardiovascular disease is now Australia's greatest health problem 
(AIHW, 1999). Next to cancer, cardiovascular disease is the second greatest cause of 
death among Australians, accounting for 52,641 deaths ( 41 % of all deaths) in 1997 
(ABS, 1999). 
The prevalence of cardiovascular conditions (ie. coronary heart disease, stroke and 
hypertension) increases quite dramatically with advancing age. For example, in 1995 
over 60% of Australians aged 75 years and over had a cardiovascular condition, 
compared to less than 9% of those aged 35 years and under (AIHW, 1999). 
Coronary heart disease is the greatest single cause of death in Australia, claiming 29,051 
lives in 1997. It is estimated that every day approximately 80 Australians die from 
coronary heart disease (HSVD, 1999). Stroke is the second greatest single cause of 
death in Australia, after coronary heart disease, claiming 12,133 lives in 1997. Stroke is 
also the leading cause oflong-term disability in adults (HSVD, 1999). 
Additionally, since the older population in Australia is expanding due to increased life 
expectancy (AIHW, 1999), investigating the causes and effects of ageing on the 
myocardium is especially important for the aged, among whom cardiovascular disease is 
most common (HSVD, 1999). 
Ageing in general is characterised by a decline in physiological function that leads to 
morbidity and eventual death (Paradies, Ruggiero, Petrosillo, Gadaleta, & Quagliariello, 
1994; Pollack & Leewenburgh, 1999; Sohal & Weindruch, 1996; Svanborg, 1997). The 
specific causes of this decline are poorly understood (Shigenaga, Hagen, & Ames, 1994), 
and many hypotheses have been proposed to try and explain the cause of ageing, the 
classic example being Harman's 1956 'free radical theory' (Goldstein, Gallo, & Reichel, 
1989; Miquel, 1998). 
17 
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The study of ageing is also complicated by the pathologic processes that become more 
prevalent with advancing age (Goldstein et al., 1989; Lakatta, 1993; Svanborg, 1997). 
Examples are diseases such as osteoporosis, atherosclerosis and primary degenerative 
dementia which often present almost identical morphological and functional changes to 
those characteristic of normal ageing (Goldstein et al., 1989; Safar, 1990; Svanborg, 
1997). 
2.2 THEORIES OF AGEING 
To believe there is a single "magic bullet" (as referred to by Bittles, 2001) cause of 
ageing is indeed naive as clearly many different tissues and systems of the body are 
altered during the ageing process. A single theory of ageing is highly unlikely to be able 
to scientifically support and explain a 'single' cause of ageing that affects the whole 
body. It would appear less naive to consider the possibility that many different theories 
could collectively explain the process of ageing. 
Currently, genetic-based theories of ageing are the most popular, stimulating research 
worldwide. Theories of ageing involving mitochondria also currently receive much 
attention. Some of the relevant theories of ageing are reviewed below. 
Genetic based theories are just that. Theories based on the concept that ageing is 
associated with changes in the genetic constitution of an individual (Bittles, 2001 ). The 
notion of 'programmed ageing' arose from lifespan studies of both mammal and non-
mammal species, with the discovery of remarkable constancy in the life expectancy of 
various species (Bittles, 1997, p. 8). Genetic based theories of ageing are also 
strengthened by the well-known finite lifespan of human diploid cells when cultured in a 
laboratory (Bittles, 2001). 
In relation to evolution, it has been suggested that ageing may be a form of natural 
selection to limit the lifespan of an individual, thereby ensuring the turnover of future 
generations. Genes of ageing were said to be 'pleiotropic' in their action, exerting 
beneficial effects when an individual was young or reproducing, followed by 
unfavourable ageing effects during an individual's later, post-reproductive years. This 
18 
notion is supported in the wild as few animals ever survive to 'old age' following their 
reproductive years (Bittles, 2001). 
The first 'evolutionary theory' of ageing was proposed by Rubner (1908; cited in Miquel, 
1998) who "observed an inverse relationship between longevity and 'rate of living', 
expressed as the amount of energy necessary for body growth" (Miquel, 1998, p. 123). 
Along similar lines, Kirkwood ( 1977) suggested that ageing was the end result of an 
'energy conservation strategy' operating in somatic cells. During an individual's lifespan, 
their total available energy is differentially allocated to a variety of functions, ie. 
macromolecular synthesis and degradation, cell and organ maintenance, and 
reproduction. Since this energy supply is finite, a compromise is reached in that the 
maximum available energy is allocated to ensure the successful transmission of genes to 
future generations (Bittles, 2001). However, after reproductive success, total energy 
available is reduced and the effects of ageing set in. 
The concept of energy and ageing is ultimately related to the source of energy 
production within the body, ie. the mitochondria. Since mitochondria supply the energy 
needed for cellular functioning, a decline in mitochondrial function with age would 
ultimately lead to an overall decline in bodily functioning within an individual. Miquel' s 
(1998) oxygen-stress mitochondrial mutation theory of ageing relates senescence to 
mutations of the mitochondrial genome (mtDNA) leading to the physiological decline 
seen with age. This theory is particularly related to postmitotic cells, such as those found 
in the myocardium (Miquel, 1998). 
Miquel' s ( 1998) theory is also related to the 'free radical theory' postulated by Harman 
in 1956, which implicates free radicals as the cause of nonspecific damage to 
macromolecules (DNA, lipids and proteins), which ultimately leads to cellular ageing and 
overall bodily senescence (Goldstein et al., 1989; Miquel, 1998). Miguel's (1998) 
'oxygen stress mitochondrial mutation theory' agrees with and expands on the 1956 'free 
radical theory' of Harman, suggesting free radicals as the 'central senescence-causing 
factor'. Of interest to note at this point is the main location of free radical production 
within the body; the mitochondria. Hence, mitochondria are akin to a 'double edged 
sword' in that they generate the crucial energy needed for cellular functioning and 
survival, as well as the free radicals that potentially destroy somatic cells. Within the 
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following literature review, a strong case is presented implicating mitochondria as 
possessing a central role in cellular and overall somatic ageing. 
2.3 AGEING MYOCARDIUM 
Cardiac function deteriorates with age (Andreu, Arbos, Perez-Martos, Lopez-Perez, 
Asin, Lopez, Montoya, & Schwartz, 1998; Hattori, Tanaka, Sugiyama, Obayashi, Ito, 
Satake, Hanaki, Asai, Nagano, & Ozawa, 1991; Paradies et al., 1994), with some 
authors postulating that ageing of the myocardium begins in the third decade of life 
(Lakatta, 1987; Muller-Hocker, 1990; Safar, 1990). However, it could be said that 
ageing of the myocardium begins in childhood with the development of a 'fatty streak' in 
the arteries that could lead to atherosclerosis and eventual cardiovascular disease 
(Cotran, Kumar & Robbins 1998, p. 503). 
With advancing age, there is an increased 'stiffening' of the cardiomyocytes, heart 
valves, mural connective tissue and the blood vessels (particularly the aorta), which 
reduces compliance in the cardiovascular system (Lakatta, 1993; Macdonald & 
O'Rourke, 1998; Safar, 1990; Svanborg, 1997). In fact it is the age related changes in 
arterial pressure, due to increased arterial 'stiffening', that physicians have used to assess 
cardiovascular ageing (Macdonald & O'Rourke, 1998). 
Perhaps the most prominent physiological characteristic associated with the ageing 
myocardium is a prolonged contraction and relaxation time (Andreu et al., 1998; 
Bhatnagar, Walford, Beard, Humphreys, & Lakatta, 1984; Fraticelli, Josephson, 
Danziger, Lakatta, & Spurgeon, 1989; Lakatta, 1987 & 1993; Lakatta & Yin, 1982; 
Muller-Hocker, 1990; Muscari, Caldarera, Rapezzi, Branzi, & Caldarera, 1992; Safar, 
1990; Svanborg, 1997; Xu & Narayanan, 1998), leading to a decreased maximal heart 
rate and ejection volume, increased end diastolic volume and decreased resting cardiac 
output (Lakatta, 1987; Muller-Hocker, 1990). 
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2.4 CONTRACTILE AND REGULATORY PROTEINS 
Muscari et al. (1992) and other authors (Fraticelli et al., 1989; Lakatta, 1987; Muller-
Hocker, 1990) have partly explained the prolonged contraction and relaxation time in 
aged myocardium by attributing it to an alteration of excitation-contraction coupling, due 
to an increased action potential duration, reduced biosynthesis of the Ca2+ -stimulated 
ATPase pump of the sarcoplasmic reticulum (SR), and the prevalence of the V3 isoform 
ofmyosin with a slow ATPase activity (Fraticelli et al., 1989; Lakatta, 1987; Muller-
Hocker, 1990; Muscari et al., 1992). 
Xu and Narayanan (1998) reported that the ATP-dependent Ca2+-uptake activity of the 
SR was significantly lower in aged myocardium and concluded that this finding was most 
likely the major factor contributing to the slow rate of myocardial relaxation seen with 
agemg. 
In addition, Fitzsimons, Patel and Moss (1999) proposed that the prolonged contraction 
and relaxation time in aged myocardium was due to the increased expression of the ~-
myosin heavy chain (MHC). In rodent heart, the normal ageing process is associated 
with a significant age-induced alteration in ventricular MHC expression, from -80% a-
MHC/20% ~-MHC at 3 months to -30% a-MHC/70% ~-MHC by 24 months 
(Fitzsimons et al., 1999). 
Fitzsimons et al. (1999) hypothesised that the increased expression of ~-MHC 
contributes to the prolonged contraction and relaxation by depressing the kinetics of 
cross-bridge interaction. Indeed, the results demonstrate that the age-related increase in 
~-MHC expression was associated with significant slowing of myocardial cross-bridge 
interaction kinetics, particularly a decline in the rates of submaximal and maximal tension 
development (Fitzsimons et al., 1999). In addition, the authors summarised that the 
ageing-dependent relationship of kinetics and ~-MHC content is consistent with the 
approximately threefold greater ATPase activity of a-MHC versus ~-MHC (Fitzsimons 
et al., 1999). 
With senescence the composition of the two principle isoenzymes ofmyosin-ATPase, VI 
and V3, shift from predominantly VI, a rapid ATPase, to predominantly V3, a slower 
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ATPase, indicating a slower rate of ATP hydrolysis in ageing myocardium (Muscari et 
al., 1992). The level of mRNA coding for the Vl isoform decreases during the lifespan 
of the rat, whilst the coding for the V3 isoform increases, indicating that contractile 
changes during ageing are, at least partially, regulated at the level of gene expression 
(Muscari et al., 1992). 
In 1996, Hill, Stewart and Verrier conducted a study investigating the 'age and 
sensitivity of rat skeletal muscle fibres to calcium and strontium'. Since the skeletal 
muscle fibres of older rats displayed increased sensitivity to calcium, but not strontium, 
compared to younger rats, it was speculated that modifications to the contractile 
proteins, particularly the myosin regulatory light chain, may occur with age (Hill et al., 
1996). 
A study by Stephenson, O'Callaghan & Stephenson (1994) using a 'skinned fibre 
technique', investigated the effects of Streptozotocin (STZ)-induced diabetes on the 
contractile and regulatory proteins of single fast (EDL-extensor digitorum longus; 
predominantly fast)- and slow (SOL-soleus; predominantly slow)-twitch skeletal muscle 
fibres from the rat. Approximately 28 days after STZ administration, 37.5% of the fast-
twitch EDL fibres developed maximum activated tensions (77 .1 ± 10. 4 kN/m2), which 
was significantly lower than maximum activated tensions developed by the controls 
(244.0 ± 14.3 kN/m2). In addition, the slow-twitch SOL fibres demonstrated a slightly 
higher sensitivity to Ca2+ ( and Sr2+) than the controls. Hence, 28 days after STZ 
treatment, the ability of many, but not all, of the fast-twitch EDL fibres to develop 
maximum tension decreases dramatically, and the sensitivity of the contractile/regulatory 
proteins to Ca2+ (and Sr2+) increased in most of the slow-twitch SOL fibres (Stephenson 
et al., 1994). 
Stephenson et al. (1994) adopted a novel approach by determining the electrophoretic 
profiles of the myofibrillar proteins in the muscle fibres that were used in their 
experiments. This validates their skinned fibre method as being able to identify and 
correlate functional changes in contractile and regulatory proteins with their chemical 
isoforms. 
22 
All of the fast-twitch EDL and slow-twitch SOL muscle fibres displayed the myofibrillar 
protein isoforms characteristic of these two major fibre types: MHC2 (myosin heavy 
chain 2), fast MLCs (myosin light chains) (MLCl-F, MLC2-F, and MLC3-F), and fast 
troponin T (TnT)-tropomyosin (Tm) complex for fast EDL fibres; and MHCl, slow 
MLCs (MLCl-S and MLC2-S), and slow TnT-Tm complex for slow-twitch SOL fibres. 
Of the fast-twitch muscle fibres found in the SOL muscles of control rats, combinations 
of both fast- and slow-twitch myofibrillar isoforms with prominent MHC2 versus MHC 1 
were seen (Stephenson et al., 1994). 
2.5 MYOCARDIAL MORPHOLOGY 
Age-related morphological changes associated with the myocardium are dominated by 
left ventricular wall and septal hypertrophy, and left atrial and ventricular widening 
(Macdonald & O'Rourke, 1998; Safar, 1990; Svanborg, 1997). According to Safar 
(1990), cardiac hypertrophy is an adaptive response to the increase in cardiac after load 
caused by age-related arterial dilation and loss of ventricular compliance. 
The hypertrophy is caused by increases in individual cardiomyocyte size (Fraticelli et al., 
1989; Macdonald & O'Rourke, 1998; Svanborg, 1997), even though the actual number 
of cardiomyocytes declines (Anversa, Palackal, Sonnenblick, Olivetti, Meggs & Capasso, 
1990; Macdonald & O'Rourke, 1998; Svanborg, 1997) by approximately 30% as the 
heart ages (Pollack & Leewenburgh, 2000). In the human heart, some 38 million nuclei 
disappear from the left ventricle each year due to either necrosis (Pollack & 
Leewenburgh, 2000) or continuous apoptosis (Macdonald & O'Rourke, 1998; Pollack & 
Leewenburgh, 2000). 
The myocardium has the ability to compensate for the loss of cardiomyocytes by 
increasing their average size (hypertrophy), hence, the ventricular fibre mass is 
regenerated during ageing (Anversa et al., 1990; Svanborg, 1997). Fraticelli et al. (1989) 
report that the average cardiomyocyte volume, measured via Coulter counter techniques, 
almost doubled between 2-24 months in rats. The authors attribute the structural basis 
for the increased volume of cardiomyocytes with age to the addition of morphologically 
similar sarcomeres, which they also implicate in the age-related prolonged contraction 
seen in aged cardiomyocytes (Fraticelli et al., 1989). 
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Fraticelli et al. (1989) also reported an increase in average cardiomyocyte length with 
age. Measured under high power light microscopy, average cardiomyocyte length in 
unattached cells increased from 133µm at 2 months, to 146µm at 6-9 months to 162µm 
at 24-25 months, in individual cardiomyocytes, isolated from rat hearts (Fraticelli et al., 
1989). 
In relation to morphological changes with ageing, a common observation in aged 
cardiomyocytes is the progressive decline in mitochondrial numbers, increases in 
mitochondrial structural abnormalities, losses in mitochondrial enzyme activities and 
decreased respiratory control (Bandy and Davison, 1990). Furthermore, mitochondria 
from older rats also demonstrate higher levels of lipid peroxides, losses of 
polyunsaturated fatty acids, and correspondingly increased oxygen free radical 
production (Bandy & Davison, 1990; Sawada & Carlson, 1987). 
Supporting these age-related changes to mitochondria, Tauchi and Sato (1968) report a 
decrease in hepatic mitochondrial numbers, however the size of individual mitochondrial 
increased with age in senescent human and rat liver (Tauchi & Sato, 1968). 
According to Tauchi & Sato (1968) the increase in size (hypertrophy) of hepatic 
mitochondria, seen with age, was considered a 'compensatory hyperfunction' for the 
decline in mitochondrial numbers. In support of this statement, Goldstein, Moerman and 
Porter (1984) also suggested that the age-related hypertrophy of mitochondria was a 
compensatory attempt to produce adequate capacity for oxidative phosphorylation 
(OXPHOS). 
In addition, Goldstein et al. (1984), using electron microscopy, also report an age-related 
increase in mitochondrial 'blebs' seen in aged (76 year old female) and progeria (5 year 
old female and 9 year old male) human fibroblasts (progeria being premature ageing). 
The authors described 'Blebs' as 'mitochondrial cystic dilations' caused by weakening or 
destruction of the inner mitochondrial membrane (IMM) which allowed outward dilation 
of the outer mitochondrial membrane (OMM) (see Figure 1). A decrease in width was 
also seen in aged and progeria human fibroblast mitochondria compared to young (11 
year old male) fibroblasts, as well as the observation that aged and progeria fibroblast 
24 
mitochondria contain less transverse cristae (Goldstein et al., 1984). With these results in 
mind, it was speculated by Goldstein et al. (1984) that since mitochondrial cristae are 
formed by in vagina ti on of the inner IMM, and blebs may result from IMM weakening; 
the decreased mitochondrial width in aged and progeria human fibroblasts may reflect a 
generalised age-dependent loss of IMM integrity which leads simultaneously to blebs and 
reduced numbers of transverse cristae. 
2.6 MITOCHONDRIA 
Mitochondria are said to be the 'powerhouse' of a cell because their metabolic activities 
provide the energy required to support the life of mammals and other aerobic organisms 
(Tortora, 1995, p. 41; Rhoades & Pflanzer, 1996, p. 87). Mitochondria (mitos, thread+ 
chondrion, granule) are small organelles present in the cytoplasm of aerobic cells, which 
may take on a variety of shapes and sizes, from long and slender with branches to short 
and fat (Martini, 2001, p. 87), spherical or highly irregular in shape (Bozzola & Russell, 
1991. p. 441). Brown (2000b) describes mitochondria as best resembling bacteria. Both 
are approximately the same size, with roughly 1 billion mitochondria fitting into a grain 
of sand. In addition, Brown (2000b) estimates that human bodies contain roughly 10 
million billion mitochondria. 
Cardiomyocytes are characterised by very large mitochondria that are densely packed 
between the myofibrils (Ross, Romrell & Kaye, 1995, p. 228), often appearing 
cylindrical, although usually flattened by the tight packing (Bers, 1991, p. 15). These 
large mitochondria often extend for the full length of a sarcomere and have abundant, 
closely packed cristae. In addition, glycogen granules are also concentrated between the 
myofibrils, hence the structures that store energy (glycogen granules) and the structures 
that release and recapture energy (mitochondria), are located adjacent to the structures 
that use the energy to drive contraction, ie. the myofibrils (Ross et al., 1995, p. 228). 
Mitochondria are unusual in that they have a double membrane: an outer mitochondrial 
membrane (OMM) surrounding the whole organelle, and an inner mitochondrial 
membrane (IMM) containing numerous folds called 'cristae' (Tortora, 1995; p. 41), 
which may be lamellar (sheet-like) or tubular in appearance (Bozzola & Russell, 1991, 
p.441). The folding cristae provide a large surface area for a group of reactions, 
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collectively known as 'cellular respiration', to take place (Tortora, 1995, p. 41, 1995). 
The area enclosed by the IMM is fluid filled, otherwise known as the mitochondrial 
'matrix' (Martini, 2001, p. 87-88; Tortora, 1995, p. 41). The structure of a 
mitochondrion is shown in Figure 1. 
Mitochondrial numbers within cells vary depending upon the type of cell and its energy 
demands (Martini, 2001, p. 87). Bers (1991) estimates that approximately 35% of the 
volume of mammalian and avian ventricular cardiomyocytes is occupied by mitochondria 
(p. 14). Further, Martini (2001, p. 87) estimates that approximately 20% of an active 
liver cell is occupied by mitochondria. However, these authors do not specify the age of 
the samples, and therefore it is assumed that they are from adult specimens. 
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Figure 1. A 3-dimensional diagram (a) and a transmission electron 
micrograph (TEM) (b) of a typical mitochondrion (TEM x 46,332). All of 
the relevant structures are labelled. Taken from Martini (2001, p. 88). 
Inner membrane 
(a) 
Outer 
membrane 
Enzymes 
Cristae Matrix 
The enzymes that catalyse the reactions involved in cellular respiration, are located on 
the cristae, with the reactions taking place within the matrix (Martini, 2001, p. 87; 
Tortora, 1995, p. 41). The cristae within cardiac mitochondria are said to be more tightly 
packed than the mitochondria of hepatocytes, which possibly reflects the more intense 
energy demands of the myocardium (Bers, 1991, p. 15). 
Cellular respiration only occurs in the presence of oxygen (02), and results in the 
catabolism of nutrient molecules ie. glucose, to generate energy in the form of adenosine 
triphosphate (ATP). Active cells eg. muscle, liver and kidney tubule cells, have large 
numbers of mitochondria, and use ATP at a high rate (Tortora, 1995, p. 41). 
The mitochondrion provides this energy by generating a proton motive force, used to 
fuel ATP synthesis, via the process of oxidative phosphorylation (OXPHOS) (Ozawa, 
1997). OXPHOS is the principle source of energy for several organs and tissue systems, 
including the brain, muscle, heart, kidney, liver and pancreatic islets. Therefore, if the 
OXPHOS process is modified, via damage to mitochondrial DNA (mtDNA), 
mitochondrial ATP production declines until it falls below the minimum energy levels 
necessary for oxidative tissues and organs to function, resulting in tissue-specific diseases 
and senescence (Wallace, 1992 & 1999). 
The OXPHOS system declines with age (Wallace, 1992). According to Ozawa (1997), 
the loss of OXPHOS capacity is related to mtDNA damage, and the accumulation of 
mtDNA mutations could be one of the main causes of disease associated with ageing. 
This interpretation, together with the known increase in the level of mtDNA mutations in 
the heart (Hayakawa, Sugiyama, Hattori, Takasawa, & Ozawa, 1993), suggests that 
cardiomyocyte mitochondrial senescence could be, at least in part, a consequence of 
accumulated mitochondrial damage (Wallace, 1992), resulting in decreased mtDNA 
transcription (Andreu et al., 1998). 
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2. 7 MITOCHONDRIAL GENETICS 
OXPHOS genetics is complicated because the genes for component peptides are 
distributed throughout both the nuclear DNA (nDNA) and mtDNA. Human mtDNA is a 
16,569-base pair (bp) closed circular molecule located within the mitochondrial matrix 
(Wallace, 1992). 
The expression of the mtDNA OXPHOS genes requires functional mitochondrial 
replication, transcription, and translation systems, and all of the polypeptides for these 
processes are encoded by the nDNA. Therefore, the biogenesis of OXPHOS requires 
hundreds of nuclear and cytoplasmic genes (Wallace, 1992, p. 629). 
In addition, the genetics of OXPHOS is further complicated by the unique characteristics 
of mtDNA inheritance. Mitochondrial DNA is almost exclusively maternally inherited 
(Brown, 2000b; Wallace, 1992 & 1999; Yowe & Ames, 1998) by offspring through the 
oocyte cytoplasm (Ozawa, 1997). Once a sperm has penetrated, it delivers a full load of 
nDNA but only a few, if any, mitochondria. However, the larger oocyte contains tens of 
thousands of mitochondria (Brown, 2000b). 
As mentioned previously, myocardial function deteriorates with age, and progressive 
age-dependent damage to mtDNA and mitochondrial functions is believed to be an 
important contributor to human ageing (Hattori et al., 1991; Ozawa, 1997). 
In recent years an abundance of mutations and deletions in mtDNA of aged myocardium, 
which could affect mtDNA transcription and result in deficient synthesis of the mtDNA 
encoded OXPHOS polypeptides, have been described (Andreu et al., 1998; Cortopassi & 
Arnheim, 1990; Hattori et al., 1991; Ozawa, 1997; Takasawa et al., 1993; Wallace, 
1999). 
Using PCR (polymerase chain reaction) techniques, Hattori et al. (1991) detected a 
7.4kb deletion ofmtDNA occurring in elderly subjects, and the proportion of deleted 
mtDNA to normal mtDNA increased with age. The deleted mtDNA fragments prevent 
the biosynthesis of some subunits of the mitochondrial energy transducing system, 
leading to inhibition of energy transduction. This effect induces a chronic ischaemia-like 
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state in the myocardium, which may contribute to the genesis of ageing heart 
(presbycardia) (Hattori et al., 1991). 
A 7.4kb deletion in mtDNA has also been identified in cardiomyopathy patients as well 
as in the myocardium of normal aged people (Miquel, 1998). As pointed out by Ozawa 
(1995), the ratio ofmtDNA with a 7.4kb deletion to total DNA increases exponentially 
with age up to 7% at age 97, with an estimated 100% mutation rate of the mtDNA at 
about 130 years of age. This might set an upper limit to longevity, since in Ozawa's 
(1995) words, "it could be speculated that 129 years may be the maximum lifespan of 
humans with regards to myocardial bioenergetic function" (p. 281 ). 
Andreu et al. (1998) studied the effect of ageing on mtDNA transcription with an in 
organello system using intact isolated rat heart mitochondria. A comparison of the 
electrophoretic patterns ofmtDNA transcription products in young (4 weeks), adult (12 
months) and senescent (24 months) rats demonstrated an age-related decrease in newly 
synthesised mitochondrial RNAs that reflects a decrease in the synthesis rate. In fact, the 
mitochondria from senescent (24 months) rat hearts synthesised RNA about 2.4 times 
less efficiently than the mitochondria of young ( 4 weeks) animals, and about 1. 5 times 
less efficiently than adult (12 months) rats. 
Mitochondrial DNA has approximately a 10-fold higher rate of mutation, is much more 
susceptible to free radical damage, and has higher turnover rates compared to nDNA 
(Yowe & Ames, 1998). This higher rate of damage and mutation to mtDNA is due to its 
location inside the inner mitochondrial membrane (IMM) near the electron transport 
chain (ETC) (Ozawa, 1997; Yowe & Ames, 1998). The ETC is a major source of 'free 
radical' production, hence mtDNA is directly susceptible to attack by free radicals 
(Ozawa, 1997). 
Furthermore, compared to nDNA, mtDNA lacks protective histones and has inefficient 
DNA repair mechanisms, therefore the mutated mitochondrial genomes tend to 
accumulate in cells, especially in stable tissues such as muscle and nerve, which consist of 
postmitotic cells (Linnane, Marzuki, Ozawa, & Tanaka, 1989; Ozawa, 1997; Yowe & 
Ames, 1998). 
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The cause of mtDNA damage leading to mutations and deletions has been postulated to 
be due to 'free radicals'. In 1956, Harman proposed a 'free radical theory' of ageing, 
implicating free radicals as the cause of nonspecific damage to macromolecules, such as 
DNA, lipids and proteins (Miquel, 1998; Ozawa, 1997). Miquel (1998) agreed with 
Harman in that 'free radicals' were the central 'senescence-causing factor'. However, the 
current information available on the mitochondrial genome led Miquel (1998) to propose 
an 'oxygen stress-mitochondrial mutation theory' of ageing in which cellular ageing 
derives from mitochondrial membrane and genetic damage caused by free radicals. 
Miquel (1998) has been able to explain better the reasons for the lack ofrepair and 
regeneration mechanisms, to counteract the harmful effects of the free radicals; 
explanations that were lacking in Harman's 1956 'free radical theory' of ageing. 
Free radical production in brain and cardiac mitochondria increases significantly with age 
(Sawada & Carlson, 1987). Sohal and Weindruch (1996) reported that the rate of free 
radical production increases generally about 15-50% during the ageing process in 
mammals. In addition, the damage caused by free radicals also increases with age 
(Muscari et al., 1992; Sohal & Weindruch, 1996). 
2.8 FREE RADICALS 
Free radicals are derived from oxygen (02) and are molecular subgroups with an 
unpaired electron in their outer orbital. This unpaired electron renders them highly 
unstable and reactive, with the potential to become destructive oxidising agents 
(Goldstein et al., 1989; Halliwell, 1994; Sawada & Carlson, 1987; Bittles, 1997, p. 11). 
Free radicals are a natural by-product of OXPHOS because electrons can be transferred 
directly from reduced flavin dehydrogenase, Coenzyme Q, and cytochrome b to oxygen 
(Wallace, 1992). As a result, about 1-4 % of the oxygen consumed by the cells is 
converted to oxygen free radicals (Finkel, 1997; Halliwell, 1994; Linnane, Baumer, 
Maxwell, Preston, Zhang & Marzuki, 1990; Pollack & Leewenburgh, 1999; Sohal & 
Weindruch, 1996, Wallace, 1992), and of that 1-4%, 98% of the oxygen metabolised is 
handled by a single enzyme, cytochrome oxidase, located in mitochondria. The 
cytochrome oxidase transfers four electrons of oxygen in an intensive reaction to 
produce two molecules of water as the end product (McCord, 2000). 
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Superoxide (02") is the major free radical produced from the utilisation of oxygen by 
mitochondria (Goldstein et al., 1989; Halliwell, 1994; Shigenaga et al., 1994; Sohal & 
Weindruch, 1996; Pollack & Leewenburgh, 1999). Superoxide (02) is produced at two 
sites in the electron transport chain (ETC), namely complex I and ubiquinone ( coenzyme 
Q) (Murphy, 2000), and since it is a charged molecule it tends to remain within the inner 
mitochondrial compartment where it is converted into hydrogen peroxide (H202). H202 
can easily diffuse through the mitochondrial membrane and other cellular membranes to 
be distributed outside the cell. However, if it is not eliminated, H202 may undergo 
transition-metal-catalysed homolytic scission to produce highly reactive hydroxyl free 
radical (Off) (Sohal & Weindruch, 1996). 
Free radicals react with other molecules to cause cellular damage and DNA mutation 
(Halliwell, 1994). Free radicals attack cell and organelle membranes, causing the lipid to 
undergo a chain reaction known as 'lipid peroxidation' (Shigenaga et al., 1994). This 
may result in severe damage and the eventual death of the cell via apoptosis (Bittles, 
2001). 
The fluidity of cellular membranes decreases with age, and this is supported by Lewin & 
Timiras's (1984) research into lipid changes with ageing in cardiac mitochondrial 
membranes. They found reduced fatty acid unsaturation of phosphatidylethanolamine, 
phosphatidylserine and phosphatidylcholine in older rats. Membrane fluidity is 
dependent upon the proportional content of saturated and unsaturated fatty acids. Young 
rat mitochondrial membranes are rich in unsaturated fatty acids and are more fluid than 
the membranes of older rats with a high proportion of saturated fatty acids. The decrease 
in membrane fluidity was also supported by the marked (approximately 260%) increase 
in cholesterol content between 4 month old and 33 month old rats used in the study. 
Such an increase in cholesterol de-fluidises the membrane by reducing thermal motion of 
the hydrocarbon (Lewin & Timiras, 1984). The decreased fluidity of cellular membranes 
is a change that may be attributed in part to oxidation of plasma and mitochondrial 
membrane lipid components by free radicals (Lewin & Timiras, 1984; Shigenaga et al., 
1994). 
Castelluccio, Baracca, Fato, Pallotti, Maranesi, Barzanti, Gorini, Villa, Castelli, 
Marchetti & Lenaz (1994) investigated the mitochondrial activities ofrat heart during 
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ageing. In support of the above mentioned study by Lewin and Timiras (1984) the 
authors also found that the fatty acid composition of the mitochondrial membranes 
revealed a percentage increase of polyunsaturated fatty acids (20:4 n-6, 22:6 n-3) up to 
12 months. However, no changes in membrane fluidity were noticed. The authors 
proposed that the fluorescence polarisation methods used to detect fluidity may not have 
been sensitive enough to reveal small fluidity changes due to variations in lipid 
unsaturation (Castelluccio et al., 1994). 
Cardiolipin, a diphosphatidyl glycerol derivative found principally within mitochondria, 
plays an important role in mitochondrial membrane structure and function. Cardiolipin 
interacts with various proteins of the inner mitochondrial membrane (IMM) and plays a 
central role in maintaining their activities (Shigenaga et al., 1994). In addition, cardiolipin 
appears to be important in controlling the permeability of the IMM to small molecules as 
well as establishing mitochondrial proton gradients (Shigenaga et al., 1994). 
Lewin and Timiras ( 1984) have reported that the content of cardiac mitochondrial 
cardiolipin decreases with age, and Paradies et al. ( 1994) found that the phospholipid 
decreased by more than 30%. Cardiolipin is required for optimal activity of cytochrome-
c-oxidase and adenine nucleotide translocase in mitochondria. Paradies et al. (1994) 
found that the activity of both cytochrome-c-oxidase and adenine nucleotide translocase 
is also reduced in the heart mitochondria of aged (28 months) rats. However, treatment 
of older rats with acetyl-L-carnitine restores the level of cardiolipin in the IMM to the 
level of young (5 months) rats (Paradies et al., 1994). 
In a study by Hudson et al. ( 1998) cytochrome-c-oxidase demonstrated an age-related 
decrease in activity. In support of this finding, Hayakawa et al. (1993) observed that the 
age-related decrease of cytochrome-c-oxidase activity in the rat heart correlates with a 
decrease in mtDNA content and an increase in 8-hydroxy-deoxyguanosine (8-0H-dG), 
an oxidative product of deoxyguanosine (dG). The authors suggest that the decrease in 
cytochrome-c-oxidase activity is the manifestation of an overall deterioration of the 
mitochondrial genome. 
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2.9 OXIDATIVE STRESS 
Overall, it seems that oxidative stress and damage increases with age because of an 
increased rate of free radical production and an increased susceptibility of tissues to free 
radical damage (Sohal & Weindruch, 1996) 
Aerobic organisms are well protected against oxidative challenges by sophisticated 
antioxidant defence systems (Pollack & Leewenburgh, 1999). The term 'antioxidant' 
usually refers to chain-breaking compounds, such as tocopherol (vitamin E). Generally 
speaking, an antioxidant is any substance that, when present at low concentrations 
compared with those of an oxidisable substrate, significantly delays or inhibits oxidation 
of that substrate (Harman, 1998). 
However, it appears that during the ageing process an imbalance between oxidant and 
antioxidant production may occur, favouring oxidants and rendering the antioxidants 
useless. This is referred to as 'oxidative stress' (Pollack & Leewenburgh, 1999; 
Halliwell, 1994). 
If mild oxidative stress occurs, tissues often respond by making extra antioxidants. 
However, severe oxidative stress can cause cell injury and death. As mentioned earlier, 
free radical induced cell death can progress as necrosis or apoptosis (Halliwell, 1994). 
2.10 APOPTOSIS 
Recently, apoptosis has been implicated as a contributing factor to cellular ageing, and 
mitochondria play a critical role (Halestrap, 2000; Brown, 2000a; Pollack & 
Leewenburgh, 2000). It was discovered that mitochondria release factors that activate 
cytoplasmic proteases and induce apoptosis. The most surprising of these factors is 
cytochrome c, which appears to play two roles: firstly as an electron-transfer protein in 
the ETC, and secondly as a signalling molecule to induce apoptosis (Cooper & 
Halestrap, 2000). 
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Mitochondrial 'damage' of some kind is required to trigger apoptosis. However, too 
much damage and the cell will be depleted of ATP, preventing apoptosis and promoting 
necrosis (Brown, 2000a). 
Cells can die in two different ways: 'chaotic explosion' or 'controlled suicide'. The 
former is known as necrosis and the latter apoptosis (Brown, 2000b). Necrosis involves 
a swelling of the cell and its intracellular organelles, culminating in plasma-membrane 
rupture and the release of intracellular proteins. Therefore, unlike apoptosis, necrosis 
induces a localised inflammatory response that can c~use further tissue injury (Halestrap, 
2000). Apoptosis, is a carefully controlled, non-inflammatory form of cell death, 
orchestrated by growth factors and cytokines, resulting in phagocytosis by macrophages 
(Brown, 2000a; Halestrap, 2000). 
Apoptosis plays a vital role in protecting the body. However, when apoptosis is 
overactivated ( eg. in neurodegenerative conditions such as Alzheimer's and Parkinson's 
diseases), an excessive number of brain neurons die. On the other hand, the inactivation 
of apoptotic processes is one of the key changes that allow cancerous cells to survive 
(Brown, 2000b). 
Mitochondria also provide a major switch for the initiation of apoptosis. This switch is 
thought to involve the opening of a nonspecific inner mitochondrial membrane (IMM) 
channel, the 'mitochondrial permeability transition pore' (mtPTP) (Yvallace 1999). The 
mtPTP is a large pore in the IMM that is normally fully closed. Opening of the pore 
allows protons to leak through, causing the mitochondria to lose their proton-motive 
force and rapidly hydrolyse cellular ATP (Brown, 2000a & b ). 
Opening of the mtPTP, followed by the death of the cell, can be initiated by the 
mitochondrion' s excessive uptake of Ca2+, increased exposure to free radicals, increased 
presence of phosphate ( conditions present during ischaemia or reperfusion) (Brown, 
2000a & b ), or a decline in energetic capacity. Thus, a noticeable reduction in 
mitochondrial energy production and a chronic increase in free radical production could 
theoretically activate the mtPTP and initiate apoptosis (Wallace, 1999). 
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The IMM space contains a number of cell death-promoting factors, including 
cytochrome c, apoptosis-inducing factor (AIF, a flavoprotein), and latent forms of 
specialised proteases called caspases. The opening of the mtPTP causes the collapse of 
Delta Psi (the transmembrane potential), swelling of IMM, and release of the above 
mentioned death-promoting factors (Wallace, 1999). Cytochrome c activates the 
cytosolic caspase protein degradation pathway, which leads to the destruction of the 
cytoplasm. AIF translocates to the nucleus, inducing chromatin destruction (Wallace, 
1999). 
Cytochrome c serves as the key regulator of apoptosis because once it is released from 
the IMM space, the cell is irreversibly committed to death. Either apoptosis occurs 
through the caspase-mediated process or the cell undergoes a necrosis-like death due to 
the collapse of the ETC. Release of cytochrome c interrupts the transfer of electrons 
between electron transport chain complexes III and IV, resulting in the generation of 
detrimental free radicals and the end of ATP synthesis (Pollack & Leewenburgh, 2000). 
Once cytochrome c has been released into the cytosol, it binds to Apaf-1 (apoptotic 
protease-activating factor 1) and, in the presence of ATP, recruits and activates 
procaspase 9 to form a complex known as the 'apoptosome'. In turn, activated caspase 9 
activates other caspases that eventually dismantle the cell (Martinou & Green, 2001). 
Apoptosis depends on ATP, and if mitochondria are damaged and fail to produce ATP in 
the early stages of apoptosis, the apoptosome cannot form and caspase 9 is not activated, 
therefore, cells die by necrosis (Martinou & Green, 2001; Brown, 2000a) 
The gene involved in the regulation of apoptosis has been identified. This gene, called 
bcl-2, is a 26 kDa protein located on the OMM (Halestrap, 2000). The gene acts to 
prevent apoptosis, allowing a cell to remain alive and functional. If something interferes 
with the function ofbcl-2, the cell will self-destruct (Martini, 2001, p. 96). 
A loss of mitochondrial function is observed during apoptosis, and since the over-
expression ofbcl-2 has previously been found to block apoptosis induced by a wide 
range of stimuli (Halestrap, 2000), it has been suggested that mitochondria may play a 
significant role in the regulation ofbcl-2 (Bittles, 2001). In support of this suggestion, 
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experimental findings have recently been produced, demonstrating that apoptosis is 
initiated following the translocation of a nuclear transcription factor, TR3, to the 
mitochondria (Li, Kolluri, Gu, Dawson, Cao, Hobbs, Lin, Chen, Lu, Lin, Xie, Fontana, 
Reed, & Zhang, 2000). The translocation of TR3, initiated by apoptotic stimuli, triggers 
the mitochondria to release cytochrome c (Li et al., 2000), the known initiator of 
apoptosis (Halestrap, 2000). 
2.11 CARDIAC ISCHAEMIA AND APOPTOSIS 
The heart is known to have one of the highest oxygen consumption rates in the body 
(Roffe, 1998), and since the heart works continuously, a reliable source of oxygen and 
other respiratory substrates is required to provide energy for the exclusive aerobic 
metabolism of the myocardium. The coronary circulation supplies blood containing these 
essentials needed by the myocardium (Martini, 2001, p. 664). Hence, even the slightest 
alteration in the blood supply to the myocardium ultimately influences cardiac efficiency. 
Energy depletion is one of the most common causes of cell death in our bodies. Cells die 
due to cessation of the blood supply (ischaemia) and therefore cessation of the 
continuous supply of respiratory substrates and oxygen. As mentioned previously, the 
main causes of death in the developed world are cardiovascular disease (including 
atherosclerosis and stroke) and cancer, which normally cause death by ischaemia of 
surrounding tissue (Brown, 2000a). 
Complete ischaemia or energy depletion, where both oxygen and glucose are absent, 
ultimately causes necrosis, blocking apoptosis, because a certain level of ATP is required 
to carry out apoptosis. However, either transient ischaemia or mitochondrial inhibitors 
can trigger apoptosis, and allow sufficient ATP in the cell to execute it (Brown, 2000a). 
Next to the brain, which is most sensitive to energy depletion, being irreversibly damaged 
within 15-30 minutes of ischaemia (eg. during a stroke), the heart is the next most 
sensitive tissue to ischaemia (Brown, 2000a). During coronary heart disease, the heart is 
often subject to ischaemia. However, reperfusion of the heart with oxygen results in a 
burst of free radical production, which contributes to the activation of the mtPTP, and 
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subsequent necrosis or apoptosis of cardiomyocytes (Brown, 2000a; Jeremias, Kupatt, 
Martin-Villalba, Habazettl, Schenkel, Boekstegers & Debatin, 2000). 
Of interest is the brief ischaemia that the myocardium, and hence the cardiomyocytes, 
would be subject to during each cardiac contraction. During a single cardiac contraction, 
the coronary blood vessels supplying the myocardium are compressed. And since left 
ventricular pressure is slightly higher than aortic pressure during systole, but less than 
aortic pressure during diastole, the blood flow through the coronary arteries that supply 
the subendocardial area of the left ventricle, will only occur during diastole. Hence, the 
left ventricular subendocardium is vulnerable to transient ischaemia, as well as being the 
most common site of myocardial infarction (Tadlock, 1996, p. 61). 
Since ischaemia followed by reperfusion results in a burst of free radical production 
(Brown, 2000a), it can be hypothesised that the myocardium is much more susceptible to 
free radical damage and subsequent cardiomyocyte apoptosis via opening of the mtPTP, 
(than perhaps the brain). This is because a burst of free radicals is produced following 
each cardiac cycle and transient ischaemia imposed on the myocardium. 
Pharmaceutical companies are currently developing drugs that block apoptosis or 
prevent the opening of the mtPTP. However, blocking apoptosis may not be very 
beneficial as 'rescued' cells may end up dying via necrosis, causing further damage. Also, 
even if necrosis was blocked, the damaged cell may function abnormally or produce free 
radicals (Brown, 2000b). 
2.12 CALORIE RESTRICTION (CR) 
It has been known for approximately 60 years that calorie restriction (CR) of 
approximately 60% of the caloric intake of an ad libitum diet, performed without 
malnutrition, extends the lifespan (LS) and maximum lifespan (MLS) of rodents, by 
approximately 40% (Harman, 1998; Pollack & Leewenburgh, 1999; Sohal & Weindruch, 
1996). 
The mechanism by which CR increases MLS is postulated to be due to a reduction in 
oxygen consumption, with a simultaneous reduction in metabolic rate and body 
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temperature in CR animals, which lowers the chronic oxidative stress with age. In 
addition, CR also retards a variety of age-related detrimental biochemical and 
physiological changes, such as the development of cancer and diabetes (Pollack & 
Leewenburgh, 1999). 
Rodents subject to CR demonstrate an attenuation of age-associated increases in rates of 
mitochondrial 0 2• and H20 2 generation, slower accumulation of free radical damage, and 
delayed loss of membrane fluidity (Sohal & Weindruch, 1996). 
Harman (1998), who proposed the 'free radical theory' of ageing in 1956, believes that 
CR increases LS by decreasing free radical reaction initiation rates. Since less free 
radicals are generated, there will be less injury to the mitochondria and their DNA, which 
overall should reduce ageing and age-associated diseases. Alternatively, CR may cause 
more efficient electron transport chain coupling, resulting in less leakage of electrons and 
therefore a decreased generation of free radicals (Harman, 1998). 
2.13 CONCLUSION 
As mentioned previously, investigating the effects of ageing on the myocardium is 
important for the future health of Australia's increasing aged population. The 
information from such investigations will contribute to the knowledge already gained 
from similar experiments by previous authors. Information yielded relating to the causes 
of ageing in general, as well as in the myocardium, is especially important from a health 
perspective in that various medical treatments can be devised to treat, and/or prolong the 
effects of ageing, to ensure maximum quality of life for aged Australians. 
Although many theories exist to explain the cause of ageing, it is highly plausible that no 
single theory is entirely correct. A combination of theories may indeed best explain the 
cause of ageing as it appears to be a very complicated process affecting almost every 
aspect of an individual's body. Hence a single theory explaining the cause of ageing 
couldn't possibly explain the far-reaching effects of this currently inevitable biological 
process. 
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Also mentioned previously was the difficulty such investigations into the cause of ageing 
have when trying to distinguish between 'normal' ageing effects as well as various 
pathological processes that present almost identical morphological and functional 
changes (Goldstein et al., 1989; Safar, 1990; Svanborg, 1997). Such pathological 
conditions include osteoporosis, atherosclerosis and primary degenerative dementia, with 
onset becoming more prevalent with advancing age (Goldstein et al., 1989; Lakatta, 
1993; Svanborg, 1997). 
The literature reviewed above appears to relate the possible cause of ageing, in general 
and in the myocardium, to alterations in the function of mitochondria, the cellular 
organelles responsible for the production of energy (ATP) required for efficient cellular 
functioning (Martini, 2001, p. 87-88). 
With age, mitochondrial numbers decrease, yet their size increases, in senescent human 
and rat hepatocytes (Tauchi & Sato, 1986). In addition, the OXPHOS system, 
responsible for the production of ATP, decreases with age (Wallace, 1992). 
It has been suggested by Ozawa (1997), that the loss ofOXPHOS capacity could be 
partly related to the accumulation of mtDNA mutations, already reported to increase 
with age by Hayakawa et al. (1993). A 7.4kb deletion ofmtDNA has also been reported 
(Miquel, 1998), and since OXPHOS components are encoded partly within mtDNA, as 
well as in nDNA (Wallace, 1992), mutations and deletions ofmtDNA ultimately affect 
the production of ATP in body cells. 
Within the current literature review, 'free radicals' have been widely postulated as the 
cause of damage to mtDNA, resulting in the mutations and deletions mentioned above 
(Lewin & Timiras, 1984; Miquel, 1998; Ozawa, 1997; Shigenaga et al., 1994). 
Apoptosis has also been related to cellular ageing, and mitochondria implicated as the 
'trigger' of apoptosis (Brown, 2000a; Halestrap, 2000; Li et al., 2000; Pollack & 
Leewenburgh, 2000; Wallace, 1992). However, some kind of mitochondrial 'damage' is 
required to 'trigger' apoptosis (Brown, 2000a), hence 'free radicals' are once again 
implicated (Wallace, 1992). 
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It has been hypothesised that the progressive loss of transcription from mutated or 
deleted DNA, leading to deficient electron transfer and ATP synthesis, and resulting in 
defective energy conservation could be the basis of ageing. This view is rapidly gaining 
support worldwide (Castelluccio et al., 1994). 
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CHAPTER 3 
MATERIALS AND METHODS 
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3.1 SUBJECTS 
Wistar rats of both sexes were used. Age groups ranged from young (n = 8, 12-30 weeks 
old), middle-aged (n = 6, 1-1.5 years old) and senescent (n = 7, 2-2.5 years old). Data 
were not obtained for all animals, as 3 rats (2 senescent, 1 young) were sacrificed for 
dissection practice, as well as trial storage of cardiac tissue in various solutions. 
Animals of the same sex were kept 2-3 per cage, and were supplied with food and water 
ad libitum, at room temperature (approximately 19-23°C). All animals used were specific 
pathogen free and obtained from the Animal Resource Centre, Murdoch University. 
Rats were an appropriate animal model to study the physiological aspects of ageing 
because, like humans, rats are omnivorous and thus have much in common concerning 
intermediary metabolism and gastrointestinal function. Their normal lifespan is 
comparatively short, up to 2.5-3 years, making it relatively easy to study them from birth 
through to death. Environment, nutrition and water-salt intakes can be easily controlled 
and rats rarely become atherosclerotic, a disorder which often complicates investigations 
into human cardiovascular ageing (Folkow & Svanborg, 1993). 
Rats in captivity are commonly referred to as 'senescent' at that age at which 
approximately 50% mortality occurs, which in many strains is approximately 2 years 
(Lakatta & Yin, 1982). 
3.2 ETHICAL CONSIDERATIONS 
Clearance for this project has been obtained from the Edith Cowan University Animal 
Experimentation Ethics Committee, approval code: OO-A8. 
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3.3 INSTRUMENTS AND EQUIPMENT 
• 
• 
Microdissecting surgical instruments, including jewellers forceps and vanna scissors 
Leica dissecting binocular microscope 
• Lynx Tissue Processor 
• LKB Nova IBtramicrotome 
• 3-Dimensional micromanipulator 
• Macintosh Maclab 2e 
• Macintosh LC 575 computer 
• Maclab GP Amp 
• Micro-force transducer, using Piezoelectric resistive strain gauges, type AME 801 
• Light microscope (with 42 point Weibel graticule) 
3.4 PROCEDURE 
Rats were anaesthetised using "Fluothal" (Halothane), then sacrificed by cervical 
dislocation. A review of the literature found no evidence ofHalothane affecting 
mitochondria. However, Halothane sensitises the heart to adrenalin (Fenton, 1995). 
The rat hearts were rapidly excised and placed into carbogenated Krebs-Henseleit 
solution (see appendix I). The hearts were dissected while in solution, and tissue samples 
removed and placed in two media. Some tissue was set aside in chilled paraffin oil, at 
approximately 4°C, for immediate contractile investigations. Other tissue dissected at the 
same time was placed in Karnovsky's fixative (see appendix II) for later histological 
processing. 
The tissue samples taken from the myocardium include left and right papillary muscles 
and ventricle. After adequate tissue samples were taken for experimental procedures, the 
remaining heart tissue was stored in Karnovsky' s fixative. 
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3.4.1 Contractile Investigations 
The contractile investigations were carried out immediately after dissection of the 
myocardial tissue, to minimise deterioration. Only tissue from the left side of the heart ie. 
left ventricle and left papillary muscles, was used for the contractile investigations. This 
was decided as i) the left side of the heart operates at a higher energy output and should 
manifest any age-related changes in function before the right side of the heart, and ii) it 
was not possible to use papillary muscles from the right side of the heart as they were 
too small for contractile investigations. 
Using methods similar to those described by Stephenson & Williams (1981) and Fink, 
Stephenson & Williams (1986), functional changes in the contractile and regulatory 
proteins that may occur as a result of ageing can be detected. This was achieved by 
immersing semi-permeable muscle preparations in solutions containing Ca2+ or Sr2+. 
Chemical treatment of muscle fibres with Triton X-100 partially disintegrates the 
sarcolemma, allowing the composition of the fluid surrounding the myofibrils to be 
directly controlled. When immersed in these solutions, muscle fibres contract, producing 
force (West, Barclay, Luff & Walker, 1999). This technique bypasses the need for 
nervous stimulation or ATP production, as ATP is provided in the activating and 
relaxing solutions. This permits analysis of the contractile apparatus and regulatory 
proteins in isolation (Hill, Stewart & Verrier, 1997). 
Strontium was used in addition to calcium, as sr2+ has several properties characteristic of 
the other divalent cation, Ca2+ (West, et al., 1999; Spencer & Berlin, 1997). Strontium 
ions are able to permeate through sarcolemmal Ca2+ channels and be transported by the 
Na+-Ca2+ exchanger, as well as bind to troponin C (Tn-C) to initiate muscle contraction 
(Spencer & Berlin, 1997). Comparing Ca2+ and Sr2+ activated contractions permits a 
greater level of comparison of functionality. 
Slow-twitch skeletal muscle fibres eg. soleus (SOL) (West et al., 1999), as well as 
cardiac muscle fibres (Kerrick, Malencik, Hoar, Potter, Coby, Pocinwong & Fischer, 
1980), have a similar sensitivity to Ca2+ and Sr2+. However, cardiac muscle fibres have 
been found to be more sensitive to Sr2+ compared to fast-twitch skeletal muscle fibres 
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(Kerrick et al., 1980), eg. flexor digitorum longus (FOL), which have a greater 
sensitivity to Ca2+ than Sr2+ (West et al., 1999). 
Hence, the use of both Ca2+ and Sr2+ solutions provides a means of greater differentiation 
between muscle fibre phenotypes (Kerrick et al., 1980; Stephenson & Williams, 1981; 
West et al., 1999). 
The contractile investigations involved dissecting small segments of myocardial tissue 
(approximately 2-3mm); tying silk sutures at either end; mounting the tissue between a 
calibrated force transducer and clamp assembly (see Figure 2, i & ii), and then placing 
the mounted tissue into a series of solutions, starting with solution I (high relaxing 
solution) (see appendix Ill) containing a detergent ('2% v/v Triton X-100'), for 
approximately 15 minutes. 
Triton X-100 chemically disintegrates the sarcolemma of cardiomyocytes, rendering 
them semi-permeable, as well as destroying the integrity of the sarcoplasmic reticulum 
(SR) and mitochondria (Harrison & Bers; 1989), therefore allowing the experimenter to 
control the intracellular environment (Bers, 1991, p. 29). 
After pre-treatment with Triton X-100, the myocardial segments were placed in a series 
of titrated, buffered activating Ca2+ (termed the 190 & 200 series) and Sr2+ (termed the 
MA & NA series) solutions, while measuring the resultant force. 
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Figure 2. (i) (Top) A photograph showing the equipment used for measuring 
force output from the individual myocardial segments. On the right, labelled 
(a) is the micromanipulator, which allows 3 dimensional movement of the 
transducer (b) and the anchoring forceps (c). The preparation was mounted 
between the transducer pin and anchoring forceps by attachment with silk 
suture. Passive stretch of the preparation was adjusted by means of a 
micrometer screw that varied the separation of the two stainless steel arms. 
The calcium or strontium solutions were held in the multiple wells in a 
rotary carousel (d), which was mounted beneath the transducer assembly. 
Figure 2. (ii) (Bottom) An enlargement of Figure 2, (i) (above) showing the 
carousel beneath the transducer pin and anchoring forceps. At the bottom 
left (arrow) is the plasticine weight used for calibrating the transducer. The 
whole assembly was rotated 90 degrees and the weight suspended from the 
transducer pin such that the force exerted was in the same alignment as for 
the tissue preparation. 
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3 .4 .1.1 Calibration 
Absolute force was calculated by first calibrating the transducer by suspending an object 
(usually a round ball of plasticine, see Figure 3, i) of known mass (see Figure 2, ii) and 
measuring the amplitude of the signal ( see Figure 3, ii). Force was calculated by 
Equation 1 below. 
Equation 1. 
Force (Newtons) = Mass of plasticine ball (Kg) X g 
Where: 
g = the gravitational acceleration constant= 9.8 m/f2 
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Figure 3. (i) (Top) A photograph showing the transducer after rotation 
through 90 degrees with the ball of plasticine (arrow) suspended from the 
pin (a). The anchoring forceps (b) have been moved sideways such that they 
do not make contact with the suture loop supporting the ball of plasticine. 
Figure 3. (ii) at bottom shows a photograph taken of the MacLab screen 
showing the electrical output of the transducer versus time during 
calibration. Several signals like this were recorded to ensure the output was 
reproducible. 
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3.4.1.2 Titrations 
The activating Ca2+ and Sr2+ solutions, of varying pCa or pSr were made by mixing 
fractions of Solution I (High Relaxing) and Solution II (activating Ca2+ or Sr2+) (see 
appendix III) in proportions predicted by 1st order rate-reaction chemistry. The amount 
of free EGTA buffer was assayed by an in-house titration method based on the methods 
of Stephenson and Williams (1981). 
An aliquot of solution was placed in a stable ionic environment adjusted to a pH of 
between 8 and 9 (see Figure 4). This was back titrated using lOOmM Calcium Chloride 
and a curve of pH versus µmol of Calcium added was plotted. (See Equation 2 below). 
Equation 2. 
EGT A.H2 + CaCh = 2HC1 + CaEGTA 
The precise amount of Calcium added was evaluated by recording the end point of the 
titration curve. If the total amount of the EGTA is known, the amount of free (unbound) 
calcium or strontium (and therefore the pCa or pSr) can be calculated by Equation 3. 
Equation 3. 
End point of titration (µmols) x Concentration of CaCh (mM) 
Volume of Aliquot (mls) 
Titrations were usually repeated twice until the pCa or pSr calculated varied by less than 
1%. 
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Figure 4. A close up photograph taken of an aliquot of calcium solution being titrated. A 
micro pH probe (arrow) is inserted to the left of the beaker. Calcium chloride solution is 
added in 10-20J.!L amounts by means of a micropipettor (a) on the right. The end-point 
of the pH change 1s measured, and the amount of free calcium (or strontium) ions 
subsequently measured. 
51 
A third solution, Solution III (low relaxing), which did not contain Ca2+ or Sr2\ was also 
used in the series to relax the tissue before another series was carried out ( see appendix 
III). This prevented any cross-contamination between solutions I and II. 
Force was measured using Piezo electric resistive strain gauges ( type AME 801) coupled 
directly to the myocardial segments via silk suture, and a 15mm stainless steel pin (see 
Figure 2, i & ii). 
The magnitude of force development provides an index of the degree of activation of the 
myofilaments by Ca2+ or Sr2+. Increasing the concentration of Ca2+ and Sr2+ in the 
activating solutions, above the threshold for contraction, results in a progressive increase 
in the production of force until the concentration is reached where all the calcium binding 
sites are occupied by either Ca2+ or sr2+ (West et al., 1999). 
Force displacement from the transducer pin generated a resistance disparity in a 
wheatstone bridge circuit connected to the general purpose amplifier of the MacLab 2e 
system. This was set in a single ended operational amplifier mode and produced an 
output in the range of 1-20mV, which was displayed on the Macintosh LC 575 computer 
using MacLab chart v3.4.3 software. 
Examination of the calcium and strontium activated force was by the mathematical 
analysis of the force-pCa or force-pSr relationship in the manner of Stephenson and 
Williams ( 1981 ). Statistical analysis was performed using the commercial software 
packages Excel 97 and Deltagraph 3. 5. 
All contractile investigations were conducted at room temperature (21-25°C). 
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3.4.2 Histology and Morphometry 
Histological techniques were used to preserve, section and stain the tissues, whilst 
morphometric techniques were used to measure the volume differences between young, 
middle-aged and senescent cardiomyocytes. 
Using histological and morphometric techniques, similar to those described in Roberts 
and McGeachie (1996) as well as Roberts, McGeachie and Grounds (1997), the volume 
of mitochondria, cytoplasm, nuclei and 'other' structures (ie. connective tissue, vascular 
space, interstitial space) was determined in the myocardial tissue samples from across the 
age range. 
To obtain these data, the tissue samples were stained with p-phenylenediamine, which 
stains mitochondria to make them visible at the light microscope level, as well as 
enabling the visualisation of nuclei and cytoplasm. Mitochondria were particularly 
targeted due to their apparent crucial involvement in cellular and overall ageing, as 
reviewed in the above literature. 
Tissue samples were taken from both the left and right side of the heart to compare age 
related changes in the volume of various structures ie. mitochondria, and relate the 
possible changes to the function of each side of the heart. 
3.4.2.1 Tissue Processing 
The tissue samples taken at the time of dissection ie. left and right papillary muscles and 
ventricle, and kept until needed in Karnovsky's fixative, were processed in a Lynx 
automatic tissue processor at 24°C with gentle agitation. Initially, the tissue samples 
were washed in cold 0.1 Molar phosphate buffer (pH 7.2) for 15 minutes before post-
fixation in 1 % Osmium Tetroxide (in distilled water) for one hour. The tissue samples 
were then washed in distilled water for 15 minutes following post-fixation before 
placement in a block-stain of 1 % p-phenylenediamine solution for one hour (prepared in 
70% ethanol). Principally for staining of mitochondria, and secondly of nuclei and 
cytoplasm. 
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Another 15 minute wash in distilled water followed staining, before the tissue samples 
were dehydrated in a series of graded ethanols, for 30 minutes/per ethanol. The tissue 
samples were then placed in pure acetone for two 30 minute sessions, followed by 
immersion in Epon Araldite (2: 1) for 12 hours and Pure Epon Araldite for 9 hours. 
Whilst still immersed in Pure Epon Araldite, the tissue samples were removed from the 
tissue processor and placed in a vacuum chamber (30 Torr, 25°C) for 30 minutes to 
remove any air/acetone bubbles from within the tissue samples. 
3.4.2.2 Embedding and Sectioning 
The tissue samples were then placed into rubber moulds and covered with the original 
Epon Araldite used during tissue processing, before placement in a 60°C oven for 24 
hours to polymerise. Sections (lµm) were cut using a LKB Nova Ultramicrotome. 
Sections were placed on microscope slides and cover-slipped for later morphometric 
analysis. 
3.4.2.3 Morphometric Analysis 
All analyses were performed on a light microscope with a 1 Ox ocular and 1 OOx oil 
immersion objective (I000x total magnification). All slides were coded and analysed 
'blindly' to avoid experimenter bias. 
Stereology is a mathematical methodology, which enables 3D values to be derived from 
2D histological sections (Weibel, 1979). Stereological techniques were used for the 
morphometric analyses as they take into account the volume of the cardiomyocytes 
occupied by mitochondria, as well as nuclei and cytoplasm. 
Unlike skeletal muscle, the morphometric examination of cardiac muscle does not pose 
the problem of oriented structures. That is, because cardiac muscle is randomly oriented 
it is an ideal candidate tissue for morphometry (Aheme & Dunnill, 1982, p.103). 
To determine the percentage volume of cardiomyocytes occupied by mitochondria, 
cytoplasm, nuclei and 'other' structures, the 'point counting' method of Weibel (1979) 
54 
~~r: 
I.; 
was used. Briefly, an eyepiece graticule containing the multipurpose test system (M42) 
was placed in the microscope eyepiece. Areas were quantitated in a clockwise direction 
in the shape of a square, beginning in the top left hand comer of a well stained area of 
tissue. Four fields of view (FOV) were counted from each section. Within each FOV, 
points falling on mitochondria, cytoplasm, nuclei were counted, with all other tissue 
components counted as 'other' eg. connective tissue, vascular space and interstitial 
space. Figure 10 is an example of a FOV at 1 OOOx magnification, with immersion oil. 
To determine the fraction (volume) that each of these components (ie. mitochondria, 
cytoplasm, nuclei and 'other' structures) occupies in a particular tissue, a method based 
on the Delesse principle was used (Aherne & Dunnill, 1982, p. 33). Briefly, the principle 
states that the fraction of the total volume occupied by a tissue component ( the volume 
density) can be directly estimated from the relative areas of the outline of that component 
viewed on random histological sections. This relationship was expressed by Weibel and 
Gomez (1962) as: 
Equation 4. 
AAi = Vvi 
Where: 
A= the area of the histological section under investigation. 
Ai= the section area occupied by profiles of a structure i. 
V = the unit volume of the cell or tissue. 
vi= represents the volume of the structure i as part of the unit volume (Roberts, 1991). 
Points were counted by projecting the point lattice (graticule) onto the histological 
sections. The ratio of the number of points lying on the component i (P i) and the total 
number of points· (Pr) within the graticule lattice is the area fraction of i. 
Equation 5. 
AAi =Pi/PT= Vvi 
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When a point fell between two structures, each structure was allocated half of one point 
(Roberts, 1991). 
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3.5 DATA ANALYSIS 
3.5.1 Contractile Investigations 
The raw experimental data took the form of force outputs displayed oscillographically 
(see Figure 5). From these, maximal force peaks were measured, and relative force was 
calculated and matched with the corresponding calcium and strontium concentrations. A 
mathematical analysis of each force-calcium/strontium relationship was undertaken 
following the methods of Stephenson and Williams (1981). Data were fitted to the Hill 
Equation (see Equation 6 below) and the following parameters recorded: 
pCa10, pCaso, Ilea, P o(Ca), pSr10, pSrso, nsr, P o(Sr), pCaso- pSrso 
Where: 
pCa10 & pCa50 = the pCa that produces 10% and 50%, respectively, of maximum 
activated force. 
Ilea= steepness of the force-pCa curves 
Po(Ca) = normalised tension (N/cm2) 
pSr10 & pSr50 = the pSr that produces 10% and 50%, respectively, of maximum activated 
force. 
nsr = steepness of the force-pSr curves 
P o(Sr) = normalised tension (N/cm2) 
pCa50- pSr50 = reflects the differential sensitivity of a muscle fibre to the two activating 
ions (Fink et al., 1986; Fink, Stephenson & Williams, 1990; Hill, Stewart & Verrier, 
1996; Stephenson et al., 1994). 
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Equation 6. Hill Equation (Hill, 1983). 
2+ 2+ 
Pr= K[X tJ(l + K[X t) 
Where: 
Pr= the relative force 
2+ 
[X ] = the concentration of the divalent cations Ca2+ and sr2+ 
n = (the Hill coefficient) is a constant determined by the slope of the force-pCa or force-
pSr curves 
K = a constant related to the lateral shift of the curves (Hill et al., 1996). 
Normalised tension (P 0) was calculated by first measuring the cross-sectional area (CSA) 
of the preparation in cm2 ( see Equation 7 below) and then multiplying the measured 
force per preparation by its reciprocal. 
Equation 7. 
CSA = Pi x r 2 
Where: 
CSA= cross-sectional area 
r = the radius of the preparation in cm 
Pi= 3.141572 
A detailed quantitative analysis of the kinetics of Ca2+ and sr2+ activation not only 
accurately describes force generation, but also provides a precise basis for demonstrating 
any age-related changes. 
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3.5.2 Histology and Morphometry 
Statistical analysis begins with an estimation of the minimum number of points that must 
fall on the structure of interest ie. mitochondria, to obtain an acceptably small standard of 
error. The following formula is employed to determine the minimum number of points 
needed to fall on a particular structure at a particular level of confidence ie. minimum 
significance level of< 0. 05. 
Equation 8. 
Where: 
RSE = the relative standard error 
Vv = the volume fraction 
RSE= 1-Vv/~ 
n = the square root of the number of points falling on the structure of interest (Roberts, 
1991). 
3.5.2.1 Arcsine Transformations 
Morphometric analysis involved performing an Arcsine Transformation to normalise the 
data yielded from the stereological analyses followed by an ANOV A to compare within 
group and between group results. A Student's t-test was used if the results were 
significant. 
As described earlier, the point counting technique was used to calculate volume densities 
using Formula 2. Since these values were proportions, a statistical analysis was 
performed on the arcsine transformed values to adjust for non-normality. 
The data derived from both the contractile investigations and the morphology were 
compared to determine (if indeed), decreased contractility was related to increased 
mitochondrial volume within cardiomyocytes. 
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3.6 LIMITATIONS 
• Age of animals 
• Number of animals 
• Number of preparations per animal 
• Number of samples 
• Deterioration of the cardiac tissue with time 
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CHAPTER 4 
RESULTS 
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4.1 CONTRACTILE INVESTIGATIONS 
A total of8 Young (12-30 weeks old), 6 middle-aged (1-1.5 years) and 7 senescent (2-
2.5 years) Wistar rats, of both sexes, were used in the present study. Of those animals, 
33 young, 44 middle-aged and 26 senescent segments of myocardial tissue from the left 
side of the heart were sampled for the contractile investigations. 
Examples of the graphical analyses are shown in Figures 6-8. Force was detected using 
an amplified microtransducer system (see methods p. 46-52). The millivolt (m V) output 
was amplifier and displayed oscillographically using a Maclab 2e system coupled to a 
Macintosh 575 computer. This allowed for continuous adjustment of both time base and 
voltage sensitivity, thus ensuring a large, clear signal was always displayed. 
Overall, the data derived from the force-pCa and force-pSr curves comparing the 3 age 
groups ie. young, middle-aged and senescent, showed no major differences. The mean 
and standard deviation data of the parameters analysed ie. pCa10, pCaso, llca, Po(Ca), 
pSr10, pSrso, nsr, P o(Sr), pCa50- pSr5o, are shown in Table 1. The data derived from 
Student's t-test (P values), also using the above parameters, are shown in Table 2, at a 
significance level of< 0.05. 
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Figure 5. (i) (Top) and (ii) (Bottom) are photographs taken of the MacLab 
screen showing examples of the electrical outputs derived during the 
contractile investigations when myocardial segments were placed in either a 
calcium (a) or strontium (b) series of solutions. The vertical lines are event 
markers indicating solution identity just before the preparation was raised 
from one carousel well and dipped into the next. The maximum voltage was 
tabulated with respect to baseline for each solution. Note the greater scale in 
m V required during the strontium series compared to the lower m V of the 
calcium series, indicating higher force outputs when myocardial segments 
were placed in the strontium solutions. Also observe the immediate decline 
in force output after the myocardial segments were placed in relaxing 
solution I (arrows) in the calcium series, whereas in strontium, force appears 
to increase or remain high for some time after placement in solution I 
(arrows). 
(i) 
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\' Figure 6. Shows a representative sample of 4 charts representing the force-
pCa (pSr) relationships derived from tissue from young animals. All curves 
display the classic sigmoidal shape typically seen with cardiac and skeletal 
muscle. There was very little variation amongst the slopes of the individual 
curves. Each of the 4 charts represents a different test animal. 
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Figure 7. Shows a representative sample of 4 charts representing the force-
pCa (pSr) relationships derived from tissue from middle-aged animals. All 
curves display the classic sigmoidal shape typically seen with cardiac and 
skeletal muscle. There was very little variation amongst the slopes of the 
individual curves. Each of the 4 charts represents a different test animal. 
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Figure 8. Shows a representative sample of 4 charts representing the force-
pCa (pSr) relationships derived from tissue from senescent animals. All 
curves display the classical sigmoidal shape typically seen with cardiac and 
skeletal muscle. It is apparent that variation amongst t~e slopes of the 
individual curves exists, as evidenced by the nca value of the senescent 
group. Each of the 4 charts represents a different test animal. 
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Figure 9. A photograph taken from the screen of the MacLab system showing maximal 
force output during Ca2+ activation at two different temperatures. The peak on the left 
(a) was achieved at 30°C, while the peak on the right (b) was a repeat at room 
temperature ie. 21-25°C. The difference in electrical output (hence force output) was 
approximately 2 times. 
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Table 1. Contractile characteristics for myocardial segments from young, middle-aged 
and senescent rats. 
Parameters Young Middle-aged Senescent 
(n = 8, 12-30 weeks) (n = 6, 1-1.5 years) (n = 7, 2-2.5 years) 
Ilca 2.35 ± 1.17 1.84 ± 0.59 2.81 ± 2.28 * 
pCa10 6.18±0.22 6.22 ± 0.05 6.10 ± 0.24 
pCaso 5.72 ± 0.18 5.67 ± 0.14 5.64±0.17 
Po(Ca) 0.05 ± 0.04 0.05 ± 0.03 0.03 ± 0.01 
nsr 1.59 ± 0.66 2.41 ±0.51 2.71 ± 1.37 
pSr10 5.60 ± 0.39 5.28 ± 0.11 5.27±0.17 
pSrso 4.90 ± 0.29 4.87 ± 0.14 4.84 ± 0.10 
Po(Sr) 0.19 ± 0.20 0.26 ± 0.19 0.10 ± 0.11 
pCaso- 0.63 ± 0.34 0.80 ± 0.08 0.77±0.18 
pSrso 
* Indicates variations within the senescent age group of animals. 
Ilea & nsr = the steepness of the force-pCa and force-pSr curves 
pCa10 & pSr10 = the pCa & pSr that produces 10% of maximum activated force; a parameter reflecting 
the threshold for activation of a muscle fibre by each activating ion. 
pCaso & pSrso = the pCa & pSr that produces 50% of maximum activated force; a parameter indicating 
the relative sensitivity of a muscle fibre to each activating ion. 
Po(Ca) & Po(Sr) = normalised tension (N/cm2) 
pCaso- pSrso = reflects the differential sensitivity of a muscle fibre to the two activating ions (Fink et al., 
1986; Fink et al., 1990; Hill, Stewart & Verrier, 1996; Stephenson et al., 1994). 
Mean ± Standard Deviation 
The slope of the force-pCa curve of senescent rats, indicated by the nCa value, displayed 
a large variation (2.81 ± 2.28) within the myocardial segments of the senescent age 
group. 
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T able 2. P values derived from Student's t-test performed on contractile data 
p 
p 
p 
p 
* 
* 
s 
0 
Parameters Young vs Young vs Middle-aged vs 
Middle-aged Senescent Senescent 
Ca10 P = 0.258 P = 0.180 P = 0.057 
Caso P = 0.247 P = 0.107 P = 0.356 
Sr10 P = 7.68xl0-5 * P = 7.66xl0-5 ** P = 0.337 
Srso P = 0.286 P=0.152 P = 0.384 
Indicates a significant difference between the young versus middle-aged age group. 
~ Indicates a significant difference between the young versus senescent age group. 
ignificant differences were seen at pSr1o between the young versus middle-aged (P < 
.05) and the young versus senescent (P < 0.05) age groups. 
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4.2 HISTOLOGY AND MORPHOMETRY 
Of the 21 animals used in the present study, a total of 3,696 points were counted from 
myocardial tissue sections cut from the 8 Young (12-30 weeks old) animals; 4,536 points 
from the 6 middle-aged (1-1.5 years) animals; and 4,032 points from the 7 senescent (2-
2.5 years) animals used. The points were counted at a significance level of 0.05. 
The percentage volume of myocardial tissue occupied by structures of interest ie. 
mitochondria, cytoplasm, nuclei and 'other' (connective tissue, interstitial space, vascular 
space), for both the left and right sides of the heart, are shown in Table 3 and Table 4 
respectively, with graphical representations in Figures 10-15. 
Figure 16 demonstrates a typical field of view (FOV), at lOOOx magnification with oil 
immersion, counted during the present study. The structures of interest are labelled, as 
well as some additional structures characteristic of myocardial tissue ie. intercalated 
discs. Figure 17 is an interesting example of an arteriole ( coronary artery/arteriole) 
within the right papillary muscles of a senescent rat. Once again various structures are 
labelled. 
The data derived from Student's t-test (P values), using the arcsine transformed values 
and the percentage volume values, from both the left and right sides of the heart, are 
shown in Table 5 and Table 6 respectively, at a significance level of< 0.05. 
In each side of the heart, data were separately derived and analysed from the papillary 
muscles and ventricle alone. The data were also combined to yield overall figures on the 
activity of the left and right sides of the heart as a whole. This was considered valid as 
papillary muscles are part of the ventricle on both sides of the heart, with both acting in 
unison when the heart is contracting. 
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4.2.1 Left Side of the Heart 
In relation to the papillary muscles on left side of the heart, statistical analyses of the 
arcsine transformed data demonstrated a significant decrease in mitochondrial volume 
between young and middle-aged rats (P < 0.05), and young and senescent rats (P < 
0.05). No significant changes in mitochondrial volume were observed between middle-
aged and senescent rats. The percentage volume of mitochondria decreased from 54.5% 
in young to 43 .1 % in middle-aged and 34.1 % in senescent rats. 
The volume of cytoplasm in left papillary muscles increased significantly between young 
and senescent rats (P < 0.05). The percentage volume of cytoplasm increased from 
31.2% in young to 37.7% in middle-aged rats; further increasing to 47.7% in senescent 
rats. No significant volume changes were observed in relation to nuclei or 'other' 
structures, across the age range in left papillary muscles. 
Statistically significant changes in the volume of mitochondria, cytoplasm, nuclei and 
'other' structures were not observed in the left ventricle of rats when compared across 
the age range. Although the percentage volume of mitochondria decreased between 
young and middle-aged rats (49.9% to 45.7% respectively), and then increased between 
middle-aged and senescent rats (45.7% to 48.7% respectively), whilst the volume of 
cytoplasm increased between young and middle-aged rats (30.2% to 34.2% respectively) 
and then decreased slightly between middle-aged and senescent rats (34.2% to 33.8%). 
Volume changes in nuclei or 'other' structures were unremarkable. 
When the data from the left side of the heart were combined, significant differences in 
mitochondrial volume were observed between young and middle-aged rats (P < 0.05) 
and young and senescent rats (P < 0.05). The percentage volume of mitochondria 
decreased from 52.2% in young to 44.4% in middle-aged rats, also decreasing from 
52.2% in young rats to 41.4% in senescent rats. 
A significant change in cytoplasmic volume was observed between young and senescent 
rats (P < 0.05), with the percentage volume of cytoplasm increasing from 30.7% in 
young to 40.8% in senescent rats. No other significant volume differences were observed 
from the combined data of the left side of the heart. 
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4.2.2 Right Side of the Heart 
On the right side of the heart, statistically significant changes in ventricular mitochondrial 
volume were observed between young and middle-aged rats (P < 0.05) and between 
middle-aged and senescent rats (P < 0.05). Between young and middle-age rats the 
percentage volume of mitochondria decreased from 48.6% to 40.0% respectively. 
Between middle-aged and senescent rats the percentage volume of mitochondria 
increased from 40.0% to 49.7% respectively. No significant changes in mitochondrial 
volume were observed between young and senescent rats. 
Between middle-aged and senescent rats, a significant (P < 0.05) decrease in 'other' 
structures ie. connective tissue, vascular space or interstitial space, was observed in the 
right ventricle. The percentage volume of 'other' structures decreased from 21.3% in 
middle-aged to 12.4% in senescent rats. No other significant volume differences were 
observed from across the age range in the right ventricle. 
In the right papillary muscles, no significant volume changes were observed across the 
age range. The percentage volume of all structures of interest demonstrated little change, 
although the volume of mitochondria increased from 43.9% in young rats to 46.0% in 
senescence, which was statistically non-significant. 
The combined data from the right ventricle and right papillary muscles demonstrated 
significant changes in mitochondrial volume between young and middle-aged rats (P < 
0.05) and middle-aged and senescent rats (P < 0.05). The percentage volume of 
mitochondria decreased from 46.3% in young to 41.8% in middle-aged rats, and then 
increased from 41. 8% in middle-aged to 4 7. 9% in senescent rats. A significant difference 
in cytoplasmic volume was also observed between young and middle-aged rats (P < 
0.05), with the percentage volume increasing from 33.0% in young to 36.9% in middle-
aged rats. 
Interestingly a significant difference in the volume of' other' structures was observed 
between middle-aged and senescent rats (P < 0.05), with the percentage volume 
decreasing from 19.4% in middle-aged to 15.0% in senescent rats. No other significant 
volume differences were observed from the combined data of the right side of the heart. 
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Table 3. Percentage volume of myocardial tissue from the left side of the heart occupied 
by structures of interest. 
Mitochondria Cytoplasm Nuclei Other Total 
Age Groups 
% % % % % 
LV 
Young 49.9 30.2 1.3 18.6 100 
Middle-aged 45.7 34.2 0.8 19.3 100 
Senescent 48.7 33.8 0.5 17.0 100 
LP 
Young 54.5 31.2 1.5 12.8 100 
Middle-aged 43.1 37.7 1.7 17.5 100 
Senescent 34.1 47.7 1.3 16.9 100 
LV&LP 
Young 52.2 30.7 1.4 15.7 100 
Middle-aged 44.4 35.9 1.3 18.4 100 
Senescent 41.4 40.8 0.9 16.9 100 
L V = Left Ventricle 
LP = Left Papillary Muscles 
L V & LP = the combined data from both the left ventricle and left papillary muscles. 
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Figure 10. Percentage volume occupied by structures of interest in left 
ventricular muscle. 
Y=Young 
MA= Middle-aged 
S = Senescent 
Mito = Mitochondria 
Cyto = Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue, vascular space, interstitial space 
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Figure 11. Percentage volume occupied by structures of interest in the left 
papillary muscles. 
Y=Young 
MA= Middle-aged 
S = Senescent 
Mita = Mitochondria 
Cyto = Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue. vascular space, interstitial space 
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Figure 12. Combined percentage volume occupied by structures of interest in left 
papillary and ventricular muscle. 
Y=Young 
MA = Middle-aged 
S = Senescent 
Mito = Mitochondria 
Cyto= Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue, vascular space, interstitial space 
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Table 4. Percentage volume of myocardial tissue from the right side of the heart, 
occupied by structures of interest. 
Mitochondria Cytoplasm Nuclei Other Total 
Age Groups 
% % % % % 
RV 
Young 48.6 32.4 2.5 16.5 100 
Middle-aged 40.0 36.9 1.8 21.3 100 
Senescent 49.7 36.1 1.8 12.4 100 
RP 
Young 43.9 33.8 2.3 20.0 100 
Middle-aged 43.6 37.0 1.9 17.5 100 
Senescent 46.0 34.9 1.4 17.7 100 
RV&RP 
Young 46.3 33.0 2.4 18.3 100 
Middle-aged 41.8 36.9 1.9 19.4 100 
Senescent 47.9 35.5 1.6 15.0 100 
RV = Right Ventricle 
RP = Right Papillary Muscles 
RV & RP = the combined data from both the right ventricle and right papillary muscles. 
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Figure 13 . Percentage volume occupied by structures of interest in right 
ventricular muscle. 
Y=Young 
MA = Middle-aged 
S = Senescent 
Mito = Mitochondria 
Cyto = Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue, vascular space, interstitial space 
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Figure 14. Percentage volume occupied by structures of interest in the right 
papillary muscles. 
Y= Young 
MA = Middle-aged 
S = Senescent 
Mito = Mitochondria 
Cyto = Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue, vascular space, interstitial space 
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Figure 15. Combined percentage volume occupied by structures of interest in 
right papillary and ventricular muscle. 
Y=Young 
MA = Middle-aged 
S = Senescent 
Mito = Mitochondria 
Cyto = Cytoplasm 
Nuclei = Nucleus/Nuclei 
Other = Connective tissue, vascular space, interstitial space 
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Table 5. P values derived from Student's t-test performed on the arcsine 
transformed data from the left side of the heart and the percentage volume 
occupied by structures of interest. 
* 
** 
Indicates a significant difference between young and middle-aged 
animals. 
Indicates a significant difference between young and senescent 
animals. 
Structures oflnterest = mitochondria, cytoplasm, nuclei and 'other' 
(interstitial space, vascular space, connective tissue). 
L V = Left Ventricle 
LP= Left Papillary Muscles 
L V & LP = the combined data from both the left ventricle and left papillary 
muscles. 
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Table 5. P values derived from Student's t-test performed on the arcsine transformed data from the left side of the heart and the percentage volume 
occupied by structures of interest. 
Structures of Interest Young vs % Volume of Young Young vs Senescent % Volume of Young Middle-aged vs % Volume of Middle-
Middle-aged vs Middle-aged vs Senescent Senescent aged vs Senescent 
LV 
Mitochondria P = 0.147 49.8% vs 45.7% P = 0.405 49.9% vs 48.7% P = 0.217 45.7% vs 48.7% 
Cytoplasm P =0.049 30.2% vs 34.2% P = 0.060 30.2% vs 33.8% P = 0.434 34.2% vs 33.8% 
Nuclei P =0.209 1.3% VS 0.8% P = 0.157 1.3% vs 0.5% P = 0.126 0.8%vs0.5% 
Other P = 0.432 18.6% VS 19.3% P = 0.378 18.6% VS 17.0% P =0.280 19.3% VS 17.0% 
LP 
Mitochondria P = 0.036 * 54.5% vs 43.1% P = 0.001 ** 54.5% VS 34.1% P = 0.103 43.1% VS 34.1% 
Cytoplasm P = 0.156 31.2% VS 37.7% P = 0.008 ** 31.2% vs 47.7% P = 0.098 37.7% vs 47.7% 
Nuclei P = 0.329 1.5% vs 1.7% P = 0.280 1.5% vs 1.3% P=0.176 1.7% vs 1.3% 
Other P =0.055 12.8% VS 17.5% P=0.115 12.8% vs 16.9% P = 0.409 17.5% VS 16.9% 
LV&LP 
Mitochondria P = 0.010 * 52.2% vs 44.4% P = 0.005 ** 52.2% vs 41.4% P = 0.219 44.4%vs41.4% 
Cytoplasm P =0.059 30.7% vs 35.9% P = 0.005 ** 30.7% vs 40.8% P =0.110 35.9% VS 40.8% 
Nuclei P = 0.329 1.4% vs 1.3% P = 0.179 1.4% vs 0.9% P =0.356 1.3% vs 0.9% 
Other P = 0.120 15.7% vs 18.4% P = 0.307 15.7% VS 16.9% P = 0.254 18.4% vs 16.9% 
Table 6. P values derived from Student's t-test performed on the arcsine 
transformed data from the right side of the heart and the percentage volume 
occupied by structures of interest. 
* 
*** 
Indicates a significant difference between young and middle-aged 
animals. 
Indicates a significant difference between middle-aged and senescent 
animals. 
Structures oflnterest = mitochondria, cytoplasm, nuclei and 'other' 
(interstitial space, vascular space, connective tissue). 
RV = Right Ventricle 
RP = Right Papillary Muscles 
RV & RP = the combined data from both the right ventricle and right 
papillary muscles. 
00 
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Table 6. P values derived from Student's t-test performed on the arcsine transformed data from the right side of the heart and the percentage volume 
occupied by structures of interest. 
Structures of Interest Young vs % Volume of Young Young vs Senescent % Volume of Young Middle-aged VS % Volume of Middle-
Middle-aged vs Middle-aged vs Senescent Senescent aged vs Senescent 
RV 
Mitochondria P = 0.Q18 * 48.6% vs 40.0% P = 0.372 48.6%·vs 49.7% P = 0.017 *** 40.0% vs 49.7% 
Cytoplasm P=0.121 32.4% VS 36.9% P = 0.182 32.4% vs 36.1 % P = 0.368 36.9% vs 36.1 % 
Nuclei P =0.277 2.5% vs 1.8% P =0.206 2.5% vs 1.8% P = 0.331 1.8% vs 1.8% 
Other P = 0.120 16.5% VS 21.3% P =0.114 16.5% vs 12.4% P = 0.004 *** 21.3% vs 12.4% 
RP 
Mitochondria P = 0.447 43.9% VS 43.6% P = 0.331 43.9% vs 46.0% P = 0.308 43.6% VS 46.0% 
Cytoplasm P=0.144 33.8% VS 37.0% P = 0.338 33.8% vs 34.9% P =0.221 37.0% VS 34.9% 
Nuclei P =0.265 2.3% VS 1.9% P = 0.063 2.3% VS 1.4% P = 0.183 1.9% vs 1.4% 
Other P = 0.145 20.0% vs 17.5% P = 0.300 20.0% VS 17.7% P = 0.482 17.5% vs 17.7% 
RV&RP 
Mitochondria P = 0.033 * 46.3% VS 41.8% P =0.239 46.3% vs 47.9% P = 0.026 *** 41.8% VS 47.9% 
Cytoplasm P =0.044 * 33.0% vs 36.9% P=0.141 33.0% VS 35.5% P = 0.217 36.9% vs 35.5% 
Nuclei P=0.178 2.4% VS 1.9% P = 0.050 2.4% VS 1.6% P = 0.186 1.9% vs 1.6% 
Other P = 0.346 18.3% vs 19.4% P =0.075 18.3% vs 15.0% P = 0.043 *** 19.4% VS 15.0% 
Figure 16. A photomicrograph of a typical field of view (FOV) counted during 
the present study, at lOOOx magnification. This tissue sample is from the left 
papillary muscle of a young rat. The characteristic structures of myocardial tissue 
are clearly seen, such as the striated appearance of the myofibrils ( t ) and the 
intercalated discs ( if' ). Nuclei are clearly seen with a central dark stained 
nucleolus ( ___,. ): Mitochondria are also visible, often between myofibrils 
(.___.).Blood vessels (coronary venules) containing red blood cells (a) are 
visible between cardiomyocytes. 
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Figure 17. A photomicrograph of a coronary arteriole within the right papillary 
muscle of a senescent rat, at 1 OOOx magnification. The lumen of the arteriole 
contains numerous red blood cells (a). Smooth muscle cells can be seen within 
the wall of the arteriole ( ~ ) as well as the connective tissue layer (b) ofthe 
tunica extema, surrounding the arteriole. The cardiomyocytes are to the right of 
the photomicrograph, and various structures such as mitochondria ( t ) and 
nuclei ( _. ) can be seen. 
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, CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
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5.1 CONTRACTILE INVESTIGATIONS 
The present study used two activating solutions, one containing Calcium ions ( Ca2+), the 
other, Strontium ions (Sr2+). As previously mentioned, sr2+ has several properties 
characteristic of the other divalent cation calcium (Ca2+) (West et al., 1999; Spencer & 
Berlin, 1997). Strontium ions are able to permeate through sarcolemmal Ca2+ channels, 
be transported by the Na+ -Ca2+ exchanger, and bind to troponin C (Tn-C) to initiate 
muscle contraction (Spencer & Berlin, 1997). 
5.1.1 Contractile Parameters 
A major finding in the contractile investigations was that the force generated in the 
cardiomyocytes was essentially the same across the age range. This suggests that young 
cardiomyocytes contract more efficiently than older cardiomyocytes as it has been shown 
by Fraticelli et al. (1989) that there is a statistically significant increase in sarcomere 
numbers in senescent (24-25 months) rat cardiomyocytes ie. young cardiomyocytes 
generate the same force as senescent cardiomyocytes, despite comparatively fewer 
sarcomeres. This will be discussed further in combination with the results of the 
histological and morphometric analyses. 
Several quantitative characteristics can be derived from a set of force-pCa and force-pSr 
curves. Of the parameters recorded during the present study, the pCa50 and pSr50 values 
represent the pCa and pSr corresponding to 50% maximum Ca2+ - and sr2+ -activated 
force responses respectively. These two characteristics are able to describe the sensitivity 
of the contractile apparatus to Ca2+ and sr2+ respectively (Fink et al., 1986; Fink et al., 
1990; Stephenson et al., 1994). During the present study, no significant differences were 
observed when the age groups were compared at pCa50 and pSr50 . 
The difference between the two, pCas0-pSr50, refer to the relative sensitivity of a 
particular fibre to Ca2+ and Sr2+ (Fink et al., 1986; Fink et al., 1990; Stephenson et al., 
1994), and have been used to describe the functional differences between slow- and fast-
twitch skeletal muscle fibres (Stephenson & Williams, 1981; West et al., 1999) as well as 
cardiac muscle fibres (Kerrick et al., 1980). No significant changes were observed during 
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the present study, when the difference between pCas0 and pSr50 (pCas0-pSrso) was 
calculated acro.ss the age ranges. 
The pCa10 and pSr10 parameters gives an indication of the contraction threshold for the 
activating ion and represents the pCa and pSr corresponding to a relative force value of 
0.1 (Fink et al., 1986; Fink et al., 1990; Stephenson et al., 1994). During the present 
study, statistical analysis of the pSr10 parameter using Student's t-test demonstrated a 
significant difference between the young and middle-aged (P < 0.05) animals, and the 
young and senescent (P < 0.05) animals, with no significant difference demonstrated 
between the middle-aged and senescent (P < 0.05) animals. It is speculated that these 
results might be a reflection of developmental changes in the TnC protein that may only 
occur early in life ie. between young and middle-age in the rat. 
It is interesting that this difference was not seen at ionic concentrations that generated 
50% relative force (ie. at pCa50 and pSr50). This could be the result of other mechanisms 
upregulating force output such as myosin light chain (MLC) phosphorylation 
(Stephenson, 1988). It might be interesting to repeat these experiments whilst regulating 
the concentration of phosphate [Pi]. 
The Ilea and nsr parameters represent numbers 'n' in the Hill equation (see Equation 6 in 
the methods section, p. 58), which provide the closest fit to the experimental points, and 
give an indication of the maximum steepness of the force-pCa and force-pSr curves (Fink 
et al., 1986; Fink et al., 1990; Stephenson et al., 1994). The slope of the force-pCa curve 
demonstrated a large variation (2.81 ± 2.28) within the myocardial segments of only the 
senescent age group during the present study. This result indicates a wide range of 
functional phenotypes of the contractile protein (myosin) in the cardiomyocytes of the 
senescent rat population itself It is hypothesised that senescent rats are at various stages 
of physiological deterioration, impacting on the function of the myosin heavy chains 
(MHC). Hence accounting for the large standard deviation of within group force-pCa 
curve results. 
The P0(Ca) and P0(Sr) parameters relate to the maximum Ca2+- and sr2+-activated 
tension (in N/cm2) developed by each myocardial segment, determined from the initial 
force response in the maximally activating Ca2+ and sr2+ solution and from the cross-
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sectional area of the myocardial segments (Stephenson et al., 1994). The cross sectional 
area (CSA) was measured whilst the myocardial segments were mounted on the force 
measuring apparatus (see methods section, p. 58), using a pre-calibrated graticule within 
a low power binocular microscope. No significant changes were observed across the age 
range during the present study, when the P 0(Ca) and P 0(Sr) parameters were calculated. 
5.1.2 Contractile and Regulatory Proteins 
During the present study, across three defined age ranges ie. young, middle-aged and 
senescent, the myocardial segments appeared to be more sensitive to solutions containing 
Sr2+ rather than Ca2+ ie. greater absolute force was produced when myocardial segments 
were maximally activated in solutions containing sr2+ rather than solutions containing 
Ca2+. Also, while not statistically significant, on average, maximum tension was reached 
at a lower pSr when compared to pCa. It was generally observed that the force output 
took 2-3 times longer to return to baseline if activated in sr2+ rather than Ca2+ (see Figure 
5, i & ii). It is speculated that this might be a reflection of a greater affinity of sr2+ to 
TnC. Additionally, the diffusion co-efficient (which is a function of the size and shape of 
the molecule) of sr2+ would be smaller than Ca2+ as the atomic weight of strontium 
(87.6) is more than double that of calcium (40.1) (Lehninger, 1975), hence slowing the 
rate of sr2+ diffusion and therefore slowing the rate of return to baseline. 
The observations from the present study are in contrast with those of Kerrick et al. 
(1980) who found rabbit and bovine cardiac muscle fibres to be equally well activated by 
sr2+ and ca2+, and hence, have similar sensitivities to both divalent cations. Also in 
contrast, Spencer and Berlin (1997) found that the binding of cardiac troponin C (TnC) 
to sr2+ is 2- to 4-fold weaker than its binding to Ca2+. However, these comparisons 
should be made cautiously, as the observed differences could be species specific. 
The prolonged contraction and relaxation time seen in aged myocardium, has often been 
attributed to age-related changes in the contractile apparatus involved in muscle 
contraction ie. the contractile and regulatory proteins. Indeed, age-related changes in the 
sensitivity of muscle fibres to Ca2+ and or sr2+ are hypothesised to be due to changes in 
the contractile and regulatory proteins with age (Hill et al., 1996; Stephenson & 
Williams, 1981; Fink et al., 1986). 
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A previously mentioned study by Hill et al. ( 1996) found that the skeletal muscle fibres 
of older (18-19 months) rats displayed increased sensitivity to Ca2+, but not Sr2+, 
compared to younger ( 5-6 months) rats. It was suggested that age-related modifications 
of the contractile proteins, particularly the regulatory myosin light chain (MLC), was the 
cause of the increased sensitivity to Ca2+, not Sr2+. 
Myocardial fibres have a similar myofibrillar protein composition to skeletal muscle fibres 
ie. a-MHC & ~-MHCs, MLCs, TnT-Tm complex, TnC and TnI; with slightly different 
isoforms (Walsh, 1987). As previously mentioned, Fitzsimons et al. (1999) attributed the 
age-related decline in cardiac function, ie. the prolongation of myocardial contraction 
and relaxation time seen with age, to changes in the expression of the ~-myosin heavy 
chain (~-MHC). The authors found that the age-related increase in the expression of~-
MHC contributes to the prolonged contraction and relaxation by depressing the kinetics 
of cross-bridge interaction, summarising that the ageing-dependent relationship of 
kinetics and ~-MHC content is consistent with the approximately threefold greater 
ATPase activity of a-MHC versus ~-MHC (Fitzsimons et al., 1999). 
Using electrophoretic techniques, Fitzsimons et al. (1999) were also able to determine 
the expression of other myofibrillar proteins, in addition to MHC. Interestingly, ageing 
was found not to alter the relative distribution of the ventricular myosin light chain 
(MLC) isoforms as well as the thin (actin) filament-associated regulatory proteins (TnT-
Tm complex, TnC & TnI). Thus, because the ventricular MHC isoforms were the only 
myocardial contractile proteins that demonstrated an age-related change in phenotypic 
expression, Fitzsimons et al. (1999) concluded that the age-related changes in the 
kinetics of myocardial cross-bridge interaction are due to age-related alterations in MHC 
expression. 
In the present study, similar age-related changes in the contractile protein myosin, as 
described above by Fitzsimons et al. (1999), would be expected. As previously 
mentioned, during the present study the nCa value derived from the senescent age group 
displayed a large variation (2.81 ± 2.28) within the myocardial segments of the age 
group. A variation postulated to be due to changes in the myosin heavy chains (MHC) 
with age, causing the large standard deviation. 
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5.1.3 Calcium Sensitivity 
Unexpected low force outputs were yielded from the Ca2+ activating solutions used 
during the present study, whilst the Sr2+ solutions activated the myocardial segments 
adequately. Two batches of Ca2+ solutions were used (termed the 190 and 200 series). 
The '190' calcium series was used for only 8 ( 4 young, 1 middle-age and 3 senescent 
rats) out of a total of 21 animals used during the present study, yielding consistent 
calcium activated force responses from the myocardial segments. On the other hand, the 
'200' calcium series activated the myocardial segments poorly, yielding depressed, if any, 
force responses. 
The '200' calcium series solutions were 're-titrated' (see Appendix IV) and were found 
slightly weaker than the' 190' series. However, allowing for this, force responses should 
have been unaffected, as the difference in Ca2+ strength between the '190' and '200' 
series was minimal ie. the pCa of the '190' solution II ( maximum activating) series was 
5. 17 compared to the pCa of the '200' series 5 .21. 
Alternatively, it was speculated that perhaps other components, other than ca2+, could 
have been mistakenly omitted or added to the solution blend in an incorrect amount eg. 
ATP or MgCh (see appendix III for correct ingredients list), or that the pH of the 
calcium solutions was too low. Mg2+ and low pH decreases the Ca2+ sensitivity of the 
cardiac myofilaments by decreasing the affinity oftroponin C (TnC) to Ca2+ (Gao, 
Backx, Azan-Backx & Marban, 1994). However, by a 'trial-and-error' process, each 
component of this solution was further added to see if force output improved. No 
changes were observed. The pH was checked and was within range. 
The protocol used by this laboratory to conduct contractile investigations using skeletal 
muscle, was employed during the present study investigating the contractile properties of 
rat myocardium. Given the poor results yielded from the contractile investigations during 
the present study, it is proposed that perhaps the protocol used should be reviewed. 
Since the time available to complete laboratory work was limited by the time constraints 
imposed by the Honours system, the formation and generation of new solutions 
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standardised for mammalian myocardial tissue activation was beyond the scope of the 
present study. 
5.1.4 Triton X-100 
Triton X-100 chemically disintegrates the sarcolemma of cardiomyocytes, rendering 
them semi-permeable, as well as destroying the integrity of the sarcoplasmic reticulum 
(SR) and mitochondria (Harrison & Bers; 1989). The results of a study by Gao et al. 
(1994) found that 'chemical skinning' using Triton X-100 decreases the calcium 
sensitivity of cardiac myofilaments. The authors postulated that the decrease in calcium 
sensitivity was due to decreased Ca2+ binding to TnC ( either by loss of natural calcium 
sensitisers or inadvertent proteolysis), alterations in MLC phosphorylation, and changes 
in cross-bridge kinetics as a result of chemical skinning ( Gao et al., 1994). 
The possibility that the use of2% Triton X-100 during the present study, was the cause 
of altered calcium sensitivity in the myocardial segments has not been overlooked. 
Further investigation into the effects of chemical skinning on cardiomyocytes is 
warranted, as clearly chemical skinning affects calcium sensitivity of skinned versus intact 
cardiomyocytes, as demonstrated by Gao et al. (1994). 
Another possibility to consider is that the branching nature of cardiomyocytes may impair 
the ability ofvarious detergent agents eg. Triton X-100, to disintegrate the sarcolemma 
sufficiently to allow the penetration of the activating solutions to generate force. 
5.1.5 Temperature and Calcium Sensitivity 
In a study by Harrison & Bers (1989), it was discovered that over the temperature range 
of 3 7°C to 1 °C there was a progressive decrease in the Ca 2+ sensitivity of the 
myofilaments with cooling in chemically skinned rabbit ventricular muscle. The authors 
attributed much of the difference between the influence of temperature on cardiac and 
skeletal muscle to the TnC type in the muscle. These conclusions were based on 
experiments where rat ventricular TnC was extracted and replaced by rabbit skeletal TnC 
or bovine cardiac TnC (Bers, 1991, p. 26). The results demonstrate an interesting 
thermodynamic difference between cardiac and skeletal muscle regulation at the level of 
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TnC, ie. cooling decreases the calcium sensitivity of cardiac myofilaments (Harrison & 
Bers, 1989), but increases the sensitivity of skeletal myofilaments (Stephenson & 
Williams, 1981); largely due to the TnC type (Bers, 1991, p. 26). 
During the present study, all contractile investigations were conducted at room 
temperature (21-25°C) using activating Ca2+ and Sr2+ solutions also kept at room 
temperature. This was done for experimental standardisation and consistency, as any 
changes in the kinetics of activation with age should manifest at this temperature. 
The cardiac tissue was kept in chilled paraffin oil at approximately 4 °C until needed. It 
was essential that the cardiac tissue be kept cool whilst not in use as it deteriorates 
rapidly when kept at room temperature. The possibility that cardiac tissue deterioration 
was occurring whilst in use ie. during a series of experimentation at room temperature 
(21-25°C), using activating Ca2+ and sr2+ solutions, has not been overruled. Even though 
it appears that increased temperature increases the calcium sensitivity of cardiac 
myofilaments (Harrison & Bers, 1989), the likelihood that the room temperature and 
time taken to perform each experiment, led to cardiac tissue deterioration and hence 
poor force responses, is still possible. 
A short experiment was conducted during the present study to test the possibility that by 
increasing the temperature of the solutions used, calcium sensitivity may also increase. 
After warming a few vials of activating calcium solutions in hot tap water to 30°C, a 
segment of myocardial tissue which was unresponsive in room temperature activating 
calcium solutions, was passed through the warmed solutions. A larger force output was 
observed, ie. 2 times greater (see Figure 9), indicating an increased response to calcium. 
However, it must be borne in mind that the transducer could be responding to the 
increase in temperature by generating a higher voltage output. A separate series of 
experiments would need to be devised to test for this and compensate for any 
electrothermal effects. 
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5.1.6 Problems Encountered 
In addition to problems involving calcium solutions and tissue deterioration, the time 
taken to complete the contractile investigations took longer than estimated, hence 
limiting the time available to conduct histological and morphometric analyses. 
Approximately 9 hours was needed to conduct contractile experiments on one animal 
alone. This was due to the complexity of the procedures involved, as well as the length 
of each protocol. The fact that myocardial tissue could not be successfully stored, either 
refrigerated or frozen, for short periods of time (ie. a day or two), made it difficult to 
derive a large amount of data from the myocardial tissue taken from one animal. 
During the present study, myocardial tissue was tested for refrigerated or frozen short-
term storage (12-24 hours) in solutions containing the following combinations: solution I 
(see appendix III) + 50% glycerol, solution I + Triton X-100, solution I + 50% glycerol 
+ Leupeptin, Krebs-Henseleit solution (see appendix I)+ 50% glycerol or Krebs-
Henseleit solution; as well as refrigerated paraffin oil. However, these tests demonstrated 
that no force could be generated from myocardial tissue after storage. Deterioration of 
the myocardial tissue was believed to be the cause. 
The laboratory in which the present study was conducted, routinely stores skeletal 
muscle successfully in solution I + 50% glycerol, either refrigerated or frozen, for up to a 
year. Force outputs from skeletal muscle stored this way are reported to be just as good 
as if the tissue were freshly harvested (A. Stewart personal communication). 
This laboratory also works with single skeletal muscle fibres. The difficulty in dissecting 
single cardiomyocytes, given the size and branching nature of cardiomyocytes compared 
to skeletal muscle fibres, led to the dissection of small myocardial segments containing 
up to approximately 20 cardiomyocytes. 
The protocol for contractile investigations used in the present study was taken from an 
existing one for single skeletal muscle fibres. It appears that refinement of the skeletal 
muscle fibre protocol, which better suits the labile nature of myocardial tissue (as 
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described above), is required. Such refinement was beyond the scope of the present 
study, but future investigations are warranted. 
5.2 HISTOLOGY AND MORPHOMETRY 
Interesting results were yielded from the morphometric analysis of the myocardial tissue 
samples taken from both the left and right sides of the rat heart. Age-related changes in 
the left side of the heart were of most interest during the present study as the left 
ventricle is responsible for pushing blood through the large systemic circuit, whereas the 
right ventricle only needs to push blood a short distance through the pulmonary circuit 
(Martini, 2001, p. 662). Although the left and right ventricle handle equal volumes of 
blood, the myocardium of the left ventricular wall is much thicker to enable the 
development of sufficient pressure to pump blood to the head and body. The 
myocardium of the right ventricle wall is thinner as it pumps blood at low pressure, 
approximately 15cm to and from the lungs (Martini, 2001, p. 662). 
With the functional differences between the left and right side of the heart in mind, the 
most intriguing finding during the present study was the fact that in the left papillary 
muscles, mitochondrial volume significantly decreases with age (P < 0.05), whereas in 
right papillary muscles, mitochondrial volume increases, although not significantly. 
Another interesting observation on the right side of the heart was that the mitochondrial 
volume of the right ventricle significantly decreased (P < 0.05) between young and 
middle-age rats with the percentage volume decreasing from 48.6% in young to 40.0% in 
middle-aged rats. However, between middle-age and senescence, the volume of 
mitochondria significantly (P < 0.05) increased from 40.0% in middle-age to 49.7% in 
senescence. 
In the left ventricle, no significant changes in mitochondrial volume were observed from 
across the age range, although mitochondrial volume decreased from 49. 8% in young to 
45.7% in middle-aged rats, and then increased from 45.7% in middle-aged to 48.7% in 
senescent rats. 
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It is speculated that these volume changes are due to age-related changes in 
mitochondrial numbers and hypertrophy of individual mitochondria. Generally speaking, 
within the literature, an age-related decrease in mitochondrial numbers is observed 
concurrently with an age-related increase in mitochondrial size (hypertrophy) (Goldstein 
et al., 1984; Tauchi & Sato, 1968). These observations have been reported from studies 
using rat and human hepatocytes (Sastre, Pallard6, Pla, Pellin, Juan, O'Connor, Estrela, 
Miquel and Vina, 1996; Tauchi and Sato, 1968) and human fibroblasts (Goldstein et al., 
1984), although Sastre et al. (1996) did not observe any age related changes in 
mitochondrial numbers. 
Using rat myocardial tissue, Frenzel and Feimann (1984) compared the structural 
changes in the myocardium of three 6 week old and three 2 year old, female Wistar rats, 
using samples taken from the side wall of both the left and right ventricle. 
5.2.1 Left Side of the Heart 
The study by Frenzel and Feimann (1984) observed that in the cardiomyocytes of 2 year 
old rats, the actual number of mitochondria had significantly increased by 42%, yet the 
mean size of a mitochondrion had significantly decreased by 36%, leading to a 9% 
reduction in the volume of mitochondria in the left ventricular wall, compared to 6 week 
old rats. The volume of myofibrils had increased by 10%, with the actual number of 
myofibrils significantly increasing by 36% in the cardiomyocytes of the left ventricular 
wall compared to 6 week old rats (Frenzel & Feimann, 1984). 
In support of Frenzel and Feimann's (1984) observations, during the present study, the 
volume of mitochondria significantly decreased (P < 0.05) by 11.4% between young and 
middle-aged rats, and by 20.4% between young and senescent rats, in the left papillary 
muscles. In addition, the volume of cytoplasm significantly increased (P < 0.05) by 6.5% 
between young and senescent rats, in the left papillary muscles. It is speculated that the 
observed age-related increase in cytoplasmic volume is related to an increased volume of 
myofibrils, as myofibrils were counted as 'cytoplasm' during the present study. 
No significant volume changes were observed in the left ventricle during the present 
study, unless combined with the data obtained from the left papillary muscles. When 
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combined, the data from both the left ventricle and left papillary muscles indicate a 
significant decrease (P < 0.05) in the volume of mitochondria between young and 
middle-aged rats, with the percentage volume decreasing from 52.2% to 44.4% 
respectively; and between young and senescent rats, with the percentage volume 
decreasing from 52.2% to 41.4% respectively. In addition, the volume of cytoplasm 
significantly increased (P < 0.05) between young and senescent rats, with percentage 
volume increasing from 30.7% to 40.8%. 
5.2.2 Right Side of the Heart 
The study by Frenzel and Feimann (1984) observed that in the cardiomyocytes of2 year 
old rats, the number of mitochondria had non-significantly increased by 9%, whilst the 
mean size of a mitochondrion decreased by 11 % in the right ventricular wall, compared 
to 6 week old rats. Mitochondrial volume changes were not recorded for the right 
ventricle, however it was stated that no significant difference was observed between the 
mitochondrial volume in the left or right ventricle of young ( 6 weeks old) compared to 
aged (2 year old) rats (Frenzel & Feimann, 1984). 
During the present study, the volume of mitochondria in the right ventricle significantly 
decreased (P < 0.05) between young and middle-aged rats, the percentage volume 
decreasing from 48.6% to 40.0% respectively. However, the volume of mitochondria 
significantly increased (P < 0.05) between middle-aged and senescent rats, the 
percentage volume increasing from 40.0% to 49.7% respectively. It is speculated that the 
decrease in mitochondrial volume seen between young and middle-aged rats is a result of 
a decrease in actual mitochondrial numbers, and between middle-aged and senescent rats, 
the remaining mitochondria are speculated to undergo hypertrophy to compensate for the 
loss of mitochondrial numbers, as previously shown by Goldstein et al. (1984) and 
Tauchi and Sato (1968). 
No significant volume changes were observed during the present study in regard to the 
right papillary muscles alone, although a non-significant increase in mitochondrial volume 
was observed between young and senescent rats, the percentage volume increasing from 
43.9% to 46.0% respectively. However, when combined, the data from both the right 
ventricle and right papillary muscles indicated a significant decrease (P < 0.05) in 
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mitochondrial volume between young and middle-aged rats, the percentage volume 
decreasing from 46.3% to 41.8% respectively. Also a significant increase (P < 0.05) in 
mitochondrial volume between middle-aged and senescent rats, the percentage volume 
increasing from 41.8% to 47.9% respectively. Once again it is speculated that between 
young and middle-aged animals, the decrease in mitochondrial volume reflects a decrease 
in mitochondrial numbers; and between middle-aged and senescent animals, the increase 
in mitochondrial volume is due to hypertrophy of the remaining mitochondria to 
compensate for the loss of mitochondrial numbers. 
Frenzel and Feimann (1984) observed that the volume of myofibrils in 2 year old rats had 
increased by 4%, with the actual number of myofibrils increasing by 12% in the right 
ventricular wall compared to 6 week old rats. In support of these results, during the 
present study, when combined, the data from both the right ventricle and the right 
papillary muscles indicated a significant increase (P < 0.05) in the volume of cytoplasm 
between young and middle-aged rats, the percentage volume increasing from 33.0% to 
36.9% respectively. Once again, since myofibrils were counted as 'cytoplasm' during the 
present study, it is speculated that the age-related increased volume of cytoplasm is due 
to an increased volume of myofibrils with age. 
Additionally, in the right ventricle alone and in the combined right ventricle and right 
papillary data, a significant decrease (P < 0.05) in 'other' structures was observed 
between middle-aged and senescent rats. The percentage volume in the right ventricle 
alone decreased from 21.3% to 12.4% between the middle-aged and senescent rats 
respectively; and in the combined right ventricle and right papillary muscles, decreased 
from 19.4% to 15.0% between the middle-aged and senescent rats respectively. 
The 'other' structures included interstitial space, vascular space and connective tissue. In 
the study by Frenzel and Feimann (1984) the interstitial space alone increased 
significantly by 52% in the right ventricle of 2 year old rats. The authors report that the 
widening of the interstitial space in 2 year old rats was due an age-related increase in 
collagen fibres, as well as oedema (cytoplasmic) and the presence of blood capillaries. 
Since the 'other' structures were found to decrease with age in the present study, it 
could be speculated that cardiomyocyte hypertrophy is occurring in the right ventricle 
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alone and in the combined right ventricle and papillary muscles, resulting in an age-
related decrease in interstitial space, vascular space and connective tissue. 
Frenzel and Feimann (1984) summarise that in the cardiomyocytes of aged (2 year old) 
rats, the quantitative alterations are more obvious in the more stressed left ventricular 
wall than in the right ventricular wall. Also that their findings signify a close relationship 
between the number of mitochondria versus myofibrils in cardiomyocytes, postulating 
that a reduced mitochondria/myofibril ratio may contribute to the diminished functional 
adaptability seen in the ageing heart (Frenzel & Feimann, 1984). 
As previously mentioned in the literature review, age-related morphological changes 
associated with the myocardium are dominated by left ventricular wall hypertrophy, 
caused by increased individual cardiomyocyte size (Macdonald & O'Rourke, 1998; 
Safar, 1990; Svanborg, 1997). Cardiomyocyte hypertrophy is an adaptive response to the 
age-related increased loss of cardiomyocytes (Anversa et al. 1990; Macdonald & 
O'Rourke, 1998; Svanborg, 1997) through necrosis (Pollack & Leewenburgh, 2000) or 
continuous apoptosis (Macdonald & O'Rourke, 1998; Pollack & Leewenburgh, 2000). 
It could be speculated that the age-related increase in myofibrillar numbers observed by 
Frenzel and Feimann (1984) in the left ventricular myocytes, is the cause of 
cardiomyocyte hypertrophy. Indeed Fraticelli et al. (1989) attribute the structural basis 
for the age-related hypertrophy of cardiomyocytes to the addition of morphologically 
similar sarcomeres. The age-related diminution of the mitochondria/myofibril ratio is 
implicated in the cause of the diminished functional adaptability seen in the ageing heart 
(Frenzel & Feimann, 1984). 
During the present study, determining age-related changes in cardiomyocyte 
mitochondrial numbers and structure, as well as changes in the myofibrillar composition, 
using electron microscopic (EM) techniques, would have provided invaluable 
information and support for the present study's findings. Unfortunately the use of EM 
techniques was beyond the scope of the present study, given the time constraints. 
However, if age-related changes in mitochondrial numbers could have been determined 
during the present study, direct correlations could have been made between the number 
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and volume of mitochondria, and the number and volume of myofibrils, in relation to 
age-related changes in the efficiency of myocardial contractility. Indeed if more 
significant data were yielded from the contractile investigations, a direct correlation 
between age-related changes in cardiomyocyte function and structure could have been 
made. 
As previously mentioned, a significant (P < 0.05) age-related decrease in mitochondrial 
volume was observed between young and middle-aged, and between young and 
senescent rats, in the left papillary muscles. This finding is speculated to be related to an 
age-related decrease in mitochondrial numbers and an increase in myofibril numbers 
and/or volume, as a significant increase (P < 0.05) in cytoplasm was also observed 
between young and senescent rats in the left papillary muscles. If the ratio of 
mitochondria to myofibrils decreases, it is speculated that a decrease in the ability of the 
cardiomyocytes to contract would be observed. 
An adequate supply of ATP to the myofibrils is required for adequate contraction of the 
cardiomyocytes. Since approximately 95% of the energy required for contraction, is 
produced by the mitochondria (Frenzel & Feimann, 1984), age-related changes in 
mitochondrial volume, numbers, functional ability and ratio to myofibrils, directly affect 
the ability of the myofibrils to contract. 
In the aged myocardium an abundance of mtDNA mutations and deletions have been 
described, which could affect mtDNA transcription, resulting in deficient synthesis of the 
mtDNA encoded OXPHOS polypeptides (Andreu et al., 1998; Hattori et al., 1991; 
Ozawa, 1997; Takasawa et al., 1993; Wallace, 1999). These mutations and deletions of 
mtDNA are postulated to be an important contributor to human ageing (Hattori et al., 
1991; Ozawa, 1997). It is speculated that the damaged mitochondria may accumulate in 
cardiomyocytes, appearing at light microscope level to be intact structurally, however 
functionally inefficient. Hence, whilst it appears that mitochondrial numbers and/or 
volume may increase with age, perhaps not all of these mitochondria are functioning 
efficiently, leading to decreased ATP production and compromised contractile ability of 
the myocardium. 
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5.3 COMBINED CONCLUSIONS 
The purpose ofthis project was to gather, analyse and compare data attained from both 
techniques ie. the contractile investigations and the morphometric analyses, to ascertain 
whether a relationship can be established between contractility and volume of 
mitochondria in cardiomyocytes with ageing. A causal relationship can be inferred, as it 
is known that cardiac function decreases with age. With mitochondria removed as the 
energy source, it was found that cardiomyocytes could generate the same contractile 
force, regardless of age, while mitochondrial volume decreased with age in the 
functionally critical left side of the heart. That cardiomyocytes can generate this force 
across the age spectrum (when mitochondrial energy is not used) may be as a result of 
the increased cytoplasm observed in this present study, which probably indicates and 
increase in the levels of contractile tissue, as observed by Frenzel and Feimann (1984). 
During the contractile investigations, minimal differences were observed in the kinetics of 
activation using exogenous Ca2+ and Sr2+ across the age spectrum. Significant (P < 0. 05) 
changes in the threshold of activation to sr2+ were observed between young and middle-
aged rats and between young and senescent rats, however not between middle-aged and 
senescent rats. Since changes in strontium sensitivity denote changes in the regulatory 
proteins of striated muscle (Stephenson et al., 1994), the age-related changes in 
threshold of activation to sr2+, are speculated to be due to functional changes in 
myocardial troponin C (TnC) that may be occurring early in life, remaining unchanged 
throughout normal ageing. 
In comparison, morphometric analyses on the myocardial tissue samples from across the 
age range indicated significant (P < 0.05) changes in the volume of various structures, 
particularly mitochondria, across all the age groups. Hence, in terms of the energy 
needed to drive myocardial contraction, changes in mitochondrial volumes were of great 
importance. 
The contractile and regulatory proteins of striated muscle do not work in isolation, but 
are controlled and influenced by the electrical, mechanical and biochemical events that 
are part of muscle contraction (Stephenson, 1988). During the present study, it was 
hoped that age-related changes in the volume of mitochondria would correlate with a 
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significant difference in the kinetics of activation of the contractile apparatus driving 
muscle contraction. The experimental outcomes of the present study did not support this 
supposition, although it was clear that there was both mitochondrial and some functional 
changes occurring with age. 
The contractile investigations provided a means of determining age-related changes to 
the contractile machinery in isolation, without the influence of the mitochondria and 
sarcoplasmic reticulum (SR), which are destroyed with chemical skinning (Harrison & 
Bers, 1989). In place of the mitochondria and SR, the activating solutions contained 
ATP and calcium (or strontium) to drive contraction. Since minimal differences were 
observed in the kinetics of activation of the isolated contractile proteins during the 
present study, it could be speculated that reported age-related changes in myocardial 
function ie. prolonged contraction and relaxation time (Andreu et al., 1998; Fraticelli et 
al., 1989; Hattori et al., 1991; Lakatta, 1993; Muscari et al., 1992; Paradies et al., 1994) 
are related to changes in mitochondria. 
During the present study, the fact that minimal differences were observed during the 
contractile investigations indicates that perhaps the contractile apparatus changes very 
little with age. In contrast, a significant change in the volume of mitochondria and 
cytoplasm was observed across the age range in both the left and right side of the heart. 
These results support the reviewed literature that implicate mitochondria as an important 
contributor to myocardial (Hattori et al., 1991; Hayakawa et al., 1993; Ozawa, 1997; 
Wallace, 1992), and overall human ageing (Castellucio et al., 1994; Hattori et al., 1991). 
Mitochondria provide the principle source of energy, in the form of adenosine 
triphosphate (ATP), via the process of oxidative phosphorylation (OXPHOS), for several 
organs, including the myocardium (Wallace, 1992). As previously mentioned, in the 
myocardium OXPHOS declines with age (Wallace, 1992) and mtDNA mutations 
increase (Hayakawa et al., 1993). 
According to Kopsidas, Kovalenko, Heffernan, Yarovaya, Kramarova, Stojanovski, 
Borg, Islam, Caragounis & Linnane (2000), the cause of the age-related decline in the 
bioenergetic capacity of a cell or tissue, particularly in postmitotic tissues, is 
hypothesised to be due to mtDNA damage and mutation accumulation that may occur 
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progressively with age until reaching a threshold level where the accumulations impinge 
on the bioenergetic capacity of the cell or tissue, often leading to cell death. 
The role of mitochondria in cell death via apoptosis is widely acknowledged (Brown, 
2000a & b; Cooper & Halestrap, 2000; Halestrap, 2000; Pollack & Leewenburgh, 2000; 
Wallace, 1999), as reviewed in the above literature review. Clearly mitochondria are 
involved in the overall physiological decline associated with advancing age, hence 
explaining why mitochondria were the focus of the present ageing related study. The 
question remains, to what extent are mitochondria involved. 
The animals used during the present study were fed ad libitum, that is, they had free 
access to food and water whenever desired. According to Sohal and Weindruch (1996), 
"Ad libitum feeding oflaboratory rodents promotes obesity and an earlier appearance of 
age associated pathologies" (p. 61). Calorie restriction (CR), without malnutrition, 
extends the maximum lifespan (MLS) of rodents by approximately 40% (Harman, 1998; 
Pollack & Leewenburgh, 1999; Sohal & Weindruch, 1996). The mechanism by which 
MLS is increased by CR is postulated to be due to a reduction in oxygen consumption 
with a simultaneous reduction in metabolic rate and body temperature, which lowered 
the known age-related increase in chronic oxidative stress (Pollack & Leewenburgh, 
1999; Sastre et al., 1996; Sohal & Weindruch, 1996). Additionally, CR retards a variety 
of age-related detrimental biochemical and physiological changes, eg. diabetes and 
cancer development (Pollack & Leewenburgh, 1999). 
Since the rats used in the present study were fed ad libitum, there is the possibility that 
this led to an age-related increase in chronic oxidative stress, and therefore increased free 
radical production and possible damage to mitochondria, particularly mitochondrial 
membranes (Sohal & Weindruch, 1996), which could have affected the volume of 
mitochondria. 
Although these effects could not be monitored during the present study, as electron 
microscopic (EM) techniques are required to investigate such structural changes to 
mitochondria, a future study using EM techniques to investigate age-related changes in 
mitochondrial morphology, using two populations of rats, one population fed ad libitum 
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the other calorie restricted, is warranted. Concurrently, the effects of CR on MLS could 
also be investigated. 
During the present study, obtaining senescent rats proved to be somewhat difficult, as it 
is highly likely that rats obtained from various breeding centres are fed ad libitum from 
birth and hence, this may reduce their MLS, leading to decreased populations of 
senescent rats ie. 2-2.5 years and older, available for such research. Ideally, breeding a 
population of rats to be fed a CR diet from birth would be the best solution, especially 
during a study such as the present, which seeks to investigate the effects of ageing on 
various physiological functions. 
6 FUTURE RESEARCH 
Although beyond the scope of the present study, many interesting research possibilities 
arose that would warrant further investigation. Particularly an investigation to determine 
any sex differences that may alter the effects of ageing on the contractility and 
mitochondrial volume of myocardial tissue. To the experimenter's knowledge, the 
literature has not reported any sex-related differences in the function and structure of the 
myocardium with ageing in any species. 
6.1 CONTRACTILE INVESTIGATIONS 
The protocol for contractile investigations used during the present study was found to be 
limited for use on myocardial tissue. This protocol works successfully on skeletal muscle 
fibres, however, it was suspected that some myocardial preparations did not activate 
maximally. 
Future work is needed to refine such protocols, especially regarding the effects of 
chemical skinning on the cardiac myofilaments, given the branching nature of 
cardiomyocytes. Also, the possibility that contractile apparatus proteins ie. TnC, are 
compromised by chemical skinning. (Gao et al., 1994), merits further investigation. It 
would be possible to conduct experiments using myocardial tissue, chemically skinned in 
various detergents eg. Triton X-100 or saponin, at various concentrations whilst 
monitoring force output. Such 'trial-and-error' experiments would determine the best 
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detergent to be used for the chemical skinning of cardiomyocytes, at the appropriate 
concentration and exposure time, to yield the best force output. 
Further, the use of activating Ca2+ and Sr2+ solutions in concentrations appropriate for 
myocardial tissue requires further appraisal, to formulate a protocol that will generate 
maximal activation with minimal inhibitory effects. 
Investigating the effect of temperature on the calcium sensitivity of cardiac myofilaments 
is another interesting aspect worth further study, given that the calcium sensitivity of 
cardiac myofilaments has been reported to decrease with decreasing temperature 
(Harrison & Bers 1989). 
Additionally, the use of genetic techniques ie. PCR, as used by Fitzsimons et al. (1999), 
would be extremely useful for determining age-related changes in the composition of the 
contractile and regulatory proteins in the myofibrils. With this information, age-related 
contractile changes could be directly correlated with changes in the composition of the 
contractile and regulatory proteins. 
Unfortunately, with the time constraints imposed, it was not possible to pursue these and 
other interesting observations further. 
6.2 HISTOLOGICAL AND MORPHOLOGICAL INVESTIGATIONS 
The use of electron microscopy would also increase the accuracy in determining 
mitochondrial volumes and profiles, as well as demonstrating structural alterations in 
mitochondrial morphology that are reported to occur with age (Goldstein et al., 1984; 
Bittles, 1989). Unfortunately the use of electron microscopic techniques was beyond the 
scope of the present study, in fact using EM techniques to investigate age related 
changes to mitochondrial numbers and morphology would constitute an Honours project 
on its own. 
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6.3 OTHER A VENUES OF FUTURE RESEARCH 
Investigations into the extent of mtDNA accumulation in myocardial tissue with age, 
using genetic techniques ie. PCR, and the physiological effects of myocardial tissue 
occupied by mutated mtDNA genomes, would be extremely useful, especially since 
mitochondria are so heavily implicated in cellular and overall ageing, as reviewed 
previously. 
Another avenue for future investigation relates to calorie restriction (CR) and its effects 
on maximum lifespan (MLS) and chronic oxidative stress in laboratory rodents, as it is 
known that CR increases MLS and decreases age-related increases in oxidative stress 
(Pollack & Leewenburgh, 1999; Sohal & Weindruch, 1996). 
The study could compare a population of rodents fed ad libitum to a population fed a CR 
diet, without malnutrition, from birth. MLS could be investigated, along with free radical 
production and the consequent structural changes to mitochondria. 
The use of electron microscopic techniques to monitor changes in mitochondrial 
morphology would be useful in such a study, as oxidative stress leads to increased free 
radical production which damages mitochondrial membranes (Sohal & Weindruch, 
1996), therefore altering mitochondrial functioning and contributing to the overall effects 
of ageing (see literature review). 
105 
7 REFERENCES 
ABS (1999). Australian Bureau of Statistics. In Australian Demographic Statistics, 
December quarter. (ABS catalogue number 3101.0). 
Aheme, W.A., & Dunnill, M.S. (1982). Morphometry. London: Edward Arnold 
Publishers. 
AIHW (1999). Heart, stroke and vascular diseases-Australian facts. Australian Institute 
of Health and Welfare. 
Andreu, A.L., Arbos, M.A., Perez-Martos, A., Lopez-Perez, M.J., Asin, J., Lopez, N., 
Montoya, J., & Schwartz, S. (1998). Reduced mitochondrial DNA transcription 
in senescent rat heart. Biochemical & Biophysical Research Communications, 
252(3), 577-581. 
Anversa, P., Palackal, T., Sonnenblick, E.H., Olivetti, G., Meggs, L.G., & Capasso, J.M. 
( 1990). Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied 
ageing rat heart. Circulation Research, 67(4), 871-885. 
Bandy, B., & Davison, A.J. (1990). Mitochondrial mutations may increase oxidative 
stress: implications for carcinogenesis and aging? Free Radical Biology & 
Medicine, 8(6), 523-539. 
Bers, D .M. ( 1991 ). Excitation-contraction coupling and cardiac contractile force. 
Boston: Kluwer Academic Publishers. 
Bhatnagar, G.M., Walford, G.D., Beard, E.S., Humphreys, S., & Lakatta, E.G. (1984). 
ATPase activity and force production in myofibrils and twitch characteristics in 
intact muscle from neonatal, adult, and senescent rat myocardium. Journal of 
Molecular & Cellular Cardiology, 16(3), 203-218. 
Bittles, A.H. (1989). The role of mitochondria in cellular ageing. In A.M. Warnes (Ed.), 
Human ageing and later life: multidisciplinary perspectives (pp. 29-37). 
London: Edward Arnold. 
Bittles, A.H. (1997). Biological aspects of human ageing. (2nd ed.). In R. Jacoby & C. 
Oppenheimer (Ed.), Psychiatry in the elderly (pp. 3-23). Oxford: Oxford 
University Press. 
Bittles, A.H. (2001). Biological aspects of human ageing. (3rd ed.). In R. Jacoby & C. 
Oppenheimer (Eds.), Psychiatry in the elderly. Oxford: Oxford University Press. 
(in press). 
Bozzola, J.J., & Russell, L.D. (1991). Electron microscopy: principles and techniques 
for biologists. Boston: Jones and Bartlett Publishers. 
Brown, G. (2000a). Energy, life and death. The Biochemist, 22(2), 11-15. 
Brown, G. (2000b). Symbionts and assassins. Natural History, 109, 66-73. 
Castelluccio, C., Baracca, A., Fato, R., Pallotti, F., Maranesi, M., Barzanti, V., Gorini, 
A., Villa, R.F., Castelli, G.P., Marchetti, M., & Lenaz, G. (1994). Mitochondrial 
activities of the rat heart during ageing. Mechanisms 
of Ageing and Development, 76, 73-88. 
Cooper, C., & Halestrap, A. (2000). Cell death: the killer within. The Biochemist, 22(2), 
9. 
Cortopassi, G.A., & Arnheim, N. (1990). Detection of a specific mitochondrial DNA 
deletion in tissues of older humans. Nucleic Acids Research, 18(23), 6927-6933. 
Cotran, R.S., Kumar, V., & Collins, T. (1998). Robbins: pathologic basis of disease. 
(6th ed.). Philadelphia: W.B. Saunders Company. 
106 
Fenton, P. (1995). Using volatile anaesthetic agents: Halothane (Fluothane). Update in 
Anaesthesia: a journal for anaesthetists in developing countries, 5, 9-10. 
Fink, R.H., Stephenson, D.G., & Williams, D.A. (1986). Calcium and strontium 
activation of single skinned muscle fibres of normal and dystrophic mice. Journal 
of Physiology, 373, 513-525. 
Fink, R.H., Stephenson, D.G., & Williams, D.A. (1990). Physiological properties of 
skinned fibres from normal and dystrophic (Duchenne) human muscle activated 
by Ca2+ and Sr2+. Journal of Physiology, 420, 337-353. 
Finkel, E. (1997). Piecing together the puzzle of aging. Lancet, 350(9085), 1150. 
Fitzsimons, D.P., Patel, J.R., & Moss, R.L. (1999). Ageing-dependent depression in the 
kinetics of force development in rat skinned myocardium. Heart and Circulatory 
Physiology, 276(5), H1511-H1519. 
Folkow, B. & Svanborg, A. (1993). Physiology of cardiovascular ageing. 
Physiological Reviews, 73(4), 725-764. 
Fraticelli, A., Josephson, R., Danziger, R., Lakatta, E., & Spurgeon, H. (1989). 
Morphological and contractile characteristics of rat cardiac myocytes from 
maturation to senescence. American Journal of Physiology, 25 7( 1 Pt 2), H259-
265. 
Frenzel, H., & Feimann, J. (1984). Age-dependent structural changes in the myocardium 
of rats: a quantitative light- and electron-microscopic study on the right and left 
chamber wall. Mechanisms of Ageing and Development, 2 7( 1 ), 29-41. 
Gao, W.D., Backx, P.H., Azan-Backx, M., & Marban, E. (1994). Myofilament Ca2+ 
sensitivity in intact versus skinned rat ventricular muscle. Circulation Research, 
73(3), 408-415. 
Goldstein, S., Gallo, J.J., & Reichel, W. (1989). Biologic theories of aging. American 
Family Physician, 40(3), 195-200. 
Goldstein, S., Moerman, E.J., & Porter, K. (1984). High-voltage electron microscopy of 
human diploid fibroblasts during ageing in vitro: morphometric analysis of 
mitochondria. Experimental Cell Research, 154( 1 ), 101-111. 
Halestrap, A (2000). Mitochondria and cell death: execution through a pore. The 
Biochemist, 22(2), 19-24. 
Halliwell, B. (1994). Free radicals, antioxidants, and human disease: curiosity, cause, or 
consequence? Lancet, 344(8924), 721-724. 
Harman, D. (1998). Extending functional life span. Experimental Gerontology, 33(1/2), 
95-112. 
Harrison, S.M., & Bers, D.M. (1989). Influence of temperature on the calcium sensitivity 
of the myofilaments of skinned ventricular muscle from the rabbit. Journal of 
General Physiology, 93(3), 411-428. 
Hattori, K., Tanaka, M., Sugiyama, S., Obayashi, T., Ito, T., Satake, T., Hanaki, Y., 
Asai, J., Nagano, M., & Ozawa, T. (1991). Age-dependent increase in deleted 
mitochondrial DNA in the human heart: possible contributory factor to 
presbycardia. American Heart Journal, 121(6 Pt 1), 1735-1742. 
Hayakawa, M., Sugiyama, S., Hattori, K., Takasawa, M., & Ozawa, T. (1993). Age-
associated damage in mitochondrial DNA in human hearts. Molecular & Cellular 
Biochemistry, 119(1-2), 95-103. 
Hill, T.L. (1983). Two elementary models for the regulation of skeletal muscle 
contraction by calcium. Biophysical Journal, 44, 383-396. 
Hill, F., Stewart, A.W., & Verrier, C.S. (1996). Age and sensitivity of rat skeletal muscle 
fibres to calcium and strontium. Basic AppliedMyology, 6(5), 373-376. 
107 
Hill, F., Stewart, AW., & Verrier, C.S. (1997). An ageing-associated decline in force 
production after repetitive contractions by rat skinned skeletal muscles fibres. 
Tissue & Cell, 29(5), 585-588. 
HSVD (1999). Heart, Stroke and Vascular Diseases: Australian facts 1999 Highlights. 
Australian Heart Foundation. 
http: //www.heartfoundation.com.au/ statistic/ contents. html. 
Hudson, E.K., Tsuchiya, N., & Hansford, R.G. (1998). Age-associated changes in 
mitochondrial mRNA expression and translation in the Wistar rat heart. 
Mechanisms of Ageing & Development, 103(2), 179-193. 
Jeremias, I., Kupatt, C., Martin-Villalba, A, Habazettl, H., Schenkel, J., Boekstegers, P., 
& Debatin, K.M. (2000). Involvement of CD95/ Apo 1/Fas in cell death after 
myocardial ischaemia. Circulation, 102(8), 915-920. 
Kerrick, W.G.L., Malencik, D.A, Hoar, P.E., Potter, J.D., Coby, R.L., Pocinwong, S., 
& Fischer, E.H. (1980). Ca2+ and Sr2+ activation: comparison of cardiac and 
skeletal muscle contraction models. Pflugers Archives-European Journal of 
Physiology, 386(3), 207-213. 
Kirkwood, T.B.L. (1977). Evolution of ageing. Nature, London, 270, 301-304. 
Kopsidas, G., Kovalenko, S.A., Heffernan, D.R., Yarovaya, N., Kramarova, L., 
Stojanovski, D., Borg, J., Islam, M.M., Caragounis, A, & Linnane, AW. (2000). 
Tissue mitochondrial DNA changes: a stochastic system. Annals of the New York 
Academy of Sciences, 908, 226-243. 
Lakatta, E.G. (1987). Cardiac muscle changes in senescence. Annual Review of 
Physiology, 49, 519-531. 
Lakatta, E.G. (1993). Cardiovascular regulatory mechanisms in advanced age. 
Physiological Reviews, 73(2), 413-467. 
Lakatta, E.G., & Yin, F.C. (1982). Myocardial aging: functional alterations and related 
cellular mechanisms. American Journal of Physiology, 242(6), H927-941. 
Lehninger, AL. (1975). Biochemistry: the molecular basis of cell structure and 
function. (3rd Ed.). New York: Worth Publishers, Inc. 
Lewin, M.B., & Timiras, P.S. (1984). Lipid changes with aging in cardiac mitochondrial 
membranes. Mechanisms of Ageing & Development, 24(3), 343-351. 
Li, H., Kolluri, S.K., Gu, J., Dawson, M.I., Cao, X., Hobbs, P.O., Lin, B., Chen, G., Lu, 
J., Lin, F., Xie, Z., Fontana, J.A, Reed, J.C., & Zhang, X. (2000). Cytochrome c 
release and apoptosis induced by mitochondrial targeting of nuclear orphan 
receptor TR3. Science, 289(5482), 1159-1164. 
Linnane, AW., Baumer, A, Maxwell, R.J., Preston, H., Zhang, C. & Marzuki, S. 
( 1990). Mitochondrial gene mutation: the ageing process and degenerative 
diseases. Biochemistry International, 22(6), 1067-1076. 
Linnane, AW., Marzuki, S., Ozawa, T., & Tanaka, M. (1989). Mitochondrial DNA 
mutations as an important contributor to ageing and degenerative diseases. 
Lancet, 1(8639), 642-645. 
Macdonald, P.S., & O'Rourke, M.F. (1998). Cardiovascular ageing and heart failure. 
Medical Journal of Australia, 169(9), 480-484. 
Martini, F.H. (2001). Fundamentals of anatomy and physiology. (5th ed.). New Jersey: 
Prentice Hall. 
Martinou, J., & Green, D.R. (2001). Breaking the mitochondrial barrier. Nature Reviews 
Molecular Cell Biology, 2(1), 63-67. 
McCord, J.M. (2000). The evolution of free radicals and oxidative stress. American 
Journal of Medicine, 108(8), 652-659. 
108 
Miquel, J. (1998). An update on the oxygen stress-mitochondrial mutation theory of 
aging: genetic and evolutionary implications. Experimental Gerontology, 33(1-
2), 113-126. 
Muller-Hocker, J. (1990). Cytochrome c oxidase deficient fibres in the limb muscle and 
diaphragm of man without muscular disease: an age-related alteration. Journal of 
the Neurological Sciences, 100(1-2), 14-21. 
Murphy, A. (2000). Mitochondria in human disease. The Biochemist, 22(2), 29-34. 
Muscari, C., Caldarera, I., Rapezzi, C., Branzi, A. & Caldarera, C.M. (1992). 
Biochemical correlates with myocardial ageing. Cardioscience, 3(2), 425-465. 
Ozawa, T. (1995). Mitochondrial DNA mutations associated with ageing and 
degenerative diseases. Experimental Gerontology, 30(3-4), 269-290. 
Ozawa, T. (1997). Genetic and functional changes in mitochondria associated with 
aging. Physiological Reviews, 77(2), 425-464. 
Paradies, G., Ruggiero, F.M., Petrosillo, G., Gadaleta, M.N., & Quagliariello, E. (1994). 
Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and 
adenine nucleotide translocase in rat heart mitochondria. FEES Letters, 350(2-3), 
213-215. 
Pollack, M., & Leewenburgh, C. (1999). Molecular mechanisms of oxidative stress in 
ageing: free radicals, ageing, antioxidants and disease. In C. K. Sen, L. Packer & 
0. Hanninem. (Ed.), Handbook of oxidants and antioxidants in exercise (pp. 
881-923): Elsevier Science B.V. 
Pollack, M., & Leewenburgh, C. (2000). Mitochondrial control of apoptosis in ageing 
and exercise. http:// grove. ufl. edu/-cleeuwen/mtapoptosis. htm. 
Rhoades, R., & Pflanzer, R. (1996). Human physiology. (3rd ed.). Philadelphia: 
Saunders College Publishing. 
Roberts, P. (1991). The effects of selected stimuli on the revascularisation and 
regeneration of skeletal muscle transplants in mice (Doctoral dissertation, 
University of Western Australia, 1991). 
Roberts, P., & McGeachie, J.K. (1996). Long-term isoprenaline administration and its 
effect on the revascularisation and regeneration of skeletal muscle transplants in 
mice. Journal of Anatomy, 188, 705-712. 
Roberts, P., McGeachie, J.K., & Grounds, M.D. (1997). The host environment 
determines strain-specific differences in the timing of skeletal muscle 
regeneration: cross-transplantation studies between SJL/J and BALB/c mice. 
Journal of Anatomy, 191, 585-594. 
Roffe, C. (1998). Ageing of the heart. British Journal of Biomedical Science, 55, 136-
148. 
Ross, M.H., Romrell, L.J., & Kaye, G.I. (1995). Histology: a text and atlas. (3rd ed.). 
Maryland: Williams & Wilkins. 
Safar, M. (1990). Ageing and its effects on the cardiovascular system. Drugs, 39, 1-8. 
Sastre, J., Pallard6, F.V., Pla, R., Pellin, A., Juan, G., O'Connor, J.E., Estrela, J.M., 
Miquel, J., & Vina, J. (1996). Ageing of the liver: age-associated mitochondrial 
damage in intact hepatocytes. Hepatology, 24(5), 1199-1205. 
Sawada, M., & Carlson, J.C. (1987). Changes in superoxide radical and lipid peroxide 
formation in the brain, heart and liver during the lifetime of the rat. Mechanisms 
of Ageing & Development, 41(1-2), 125-137. 
Shigenaga, M.K., Hagen, T.M., & Ames, B.N. (1994). Oxidative damage and 
mitochondrial decay in aging. Proceedings of the National Academy of Sciences 
of the United States of America, 91(23), 10771-10778. 
Sohal, RS., & Weindruch, R. (1996). Oxidative stress, caloric restriction, and aging. 
Science, 273(5271), 59-63. 
109 
l 
Spencer, C.I., & Berlin, J.R. (1997). Calcium-induced release of strontium ions from the 
sarcoplasmic reticulum of rat cardiac ventricular myocytes. Journal of 
Physiology, 504(3), 565-578. 
Stephenson, D.G. (1988). Contractile activation of skeletal and cardiac muscle by 
calcium. Proceedings of the Australian Physiological and Pharmacological 
Society, 19, 108-122. 
Stephenson, G.M.M., O'Callaghan, A., & Stephenson., D.G. (1994). Single fibre study 
of contractile and biochemical properties of skeletal muscles in Streptozotocin-
induced diabetic rats. Diabetes, 43, 622-628. 
Stephenson, D.G. & Williams, D.A. (1981). Calcium-activated force responses in fast-
and slow- twitch skinned muscle fibres of the rat at different temperatures. 
Journal of Physiology, 317, 281-302. 
Svanborg, A. (1997). Age-related changes in cardiac physiology. Can they be postponed 
or treated by drugs? Drugs & Aging, 10(6), 463-472. 
Tadlock, C.H. (1996). Physiology: an illustrated review with questions and 
explanations. (2nd ed.). New York: Little, Brown and Company. 
Takasawa, M., Hayakawa, M., Sugiyama, S., Hattori, K., Ito, T., & Ozawa, T. (1993). 
Age-associated damage in mitochondrial function in rat hearts. Experimental 
Gerontology, 28(3), 269-280. 
Tauchi, H., & Sato, T. (1968). Age changes in size and number of mitochondria of 
human hepatic cells. Journal of Gerontology, 23(4), 454-461. 
Tortora, G.J. (1995). Principles of human anatomy. (7th ed.). New York: HarperCollins 
College Publishers. 
Wallace, D.C. (1992). Mitochondrial genetics: a paradigm for ageing and degenerative 
diseases? Science, 256, 628-638. 
Wallace, D.C. (1999). Mitochondrial diseases in man and mouse. Science, 283(5407), 
1482-1488. 
Walsh, T.P. (1987). Molecular regulation of thick and thin filaments: to control or be 
controlled. Proceedings of the Australian Physiological and Pharmacological 
Society, 18(2), 79-88. 
Weibel, E.R. (1979). Stereological methods: Vol. 1. Practical methods for biological 
morphometry. London: Academic Press. 
Weibel, E.R., & Gomez, D.M. (1962). A principle for counting tissue structures on 
random sections. Journal of Applied Physiology, 17, 343-348. 
West, J.M., Barclay, C.J., Luff, AR., & Walker, D.W. (1999). Developmental changes 
in the activation properties and ultrastructure of fast- and slow-twitch muscles 
from fetal sheep. Journal of Muscle Research and Cell Motility, 20, 249-264. 
Wilson, G.J., & Stephenson, D.G. (1990). Calcium and strontium activation 
characteristics of skeletal muscle fibres from the small marsupial Sminthopsis 
macroura. Journal of Muscle Research and Cell Motility, JO, 12-24. 
Xu, A., & Narayanan., N. (1998). Effects of ageing on sarcoplasmic reticulum ca2+_ 
cycling proteins and their phosphorylation in rat myocardium. American Journal 
of Physiology, 275(6), 2087-2094. 
Yowe, D. L., & Ames, B.N. (1998). Quantitation of age-related mitochondrial DNA 
deletions in rat tissues shows that their pattern of accumulation differs to that of 
humans. Gene, 209, 23-30. 
110 
I\ .. 8 APPENDICES 
111 
8.1 APPENDIX I 
8.1.1 Krebs-Henseleit Solution 
(mMol/L) 
NaCl 59mM 
NaHC03 14.2mM 
! ,, 
I KCl 2.38 mM MgS04 0.9mM 
I KH2P04 0.59mM 
D-Glucose lOmM 
Insulin 0.01 u/ml 
CaCb 25.4 ml of 100 mM 
l 112 
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8.2 APPENDIX II 
8.2.1 Karnovsky's Fixative 
Buffer 
Paraformaldehyde 
Glutaraldehyde 
Distilled Water 
0.2M 
10% 
25% 
to desired amount 
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8.3 APPENDIX III 
8.3.1 Activating and Relaxing Solutions 
(Series 190 & 200 Calcium) 
(Series MA & NA Strontium) 
Solution I 
(high-relaxing) 
HEPES 60mM 
MgCh lmM 
HDTA -
EGTA SOmM 
Sodium Azide lmM 
Caffeine lOmM 
ATP 8mM 
Ca Ch ( or SrCh) -
Abbreviations 
Solution II ( activating) 
60mM 
lmM 
-
SOmM 
lmM 
lOmM 
8mM 
48.5 mM (36.0 mM) 
Solution III 
(low-relaxing) 
60mM 
lmM 
SOmM 
-
lmM 
lOmM 
8mM 
-
HEPES = N-[2-Hydroxyethyl]piperazine-N' -[2-ethanesulphonic acid] 
HDTA = 1,6-Diaminohexane-N,N,N',N-tetraacetic acid 
EGTA = Ethylene glycol-bis(~-aminoethyl ether) N.N,N, ',N-tetraacetic acid 
ATP= Adenosine 5'-triphosphate (Hill et al., 1996). 
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9 BUDGET 
Animal costs: 
Wistar Rats: 23 x $16- = $368-
Consumables including: 
Chemicals, buffer, enzymes, Ringer chemicals: $500-
Surgical Instruments: $100-
Bedding and food for animals: $200-
TOTAL: $1,168-
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